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Substance abuse treatment outcome studies have shown positive effects for a large 
number of drug users with regard to reduction in substance use and criminal activity, as 
well as improvement of general well-being. However, high rates of relapse following 
treatment have compelled researchers to elucidate the individual difference factors that 
change among those who receive substance abuse treatment. Affect- (depressive and 
anxiety symptoms) and disinhibition–related variables (impulsivity, risk taking) may be 
of particular relevance. These factors are related to the development and maintenance of 
substance use and distinguish between substance users with and without Axis I and II 
disorders that may interfere with treatment success, such as depression, anxiety disorders, 
or antisocial personality disorder. Consequently, these factors may be considered 
important treatment targets. However, there currently is a dearth of research focused on 
understanding whether these variables are affected by standard substance use treatments, 
and more specifically, which variables may change throughout the course of substance 
use treatment. Given that many of these variables are considered to be enduring aspects 
of an individual’s personality, the extent to which they are malleable by treatment is an 
important consideration. Moreover, to enhance the generalizability of these findings, it is 
important to understand the extent to which changes occur in more standard substance 
use treatments as opposed to more elaborate and targeted treatments that rarely are 
disseminated in real world treatment settings. Therefore, the purpose of the current study 
was to examine the effect of a residential substance use treatment program on particular 
affect- (e.g., depressive and anxiety symptoms, stress reactivity) and disinhibition-related 
variables (e.g., risk taking). A sample of 81 inner-city substance abusers were assessed on 
self-reported and behavioral measures of the above affect- and disinhibition-related 
variables that have previously found to be implicated in substance use over a 30-day 
course of treatment. A residential treatment program provides an optimal setting for 
evaluating changes as behavioral confounds (i.e., substance use) can be controlled, and 
the natural changes during abstinence can be measured with both reliability and validity. 
A significant pre-post treatment decrease was found on scores of risk taking, as indexed 
by the Balloon Analogue Risk Task (BART); levels of depressive symptomatology and 
stress reactivity also evidenced a significant pre-post decrease. These data are discussed 
with respect to implications for understanding the factors that underlie mechanisms of 
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Chapter 1: Theoretical Rationale 
Introduction 
Substance use (e.g., drug, alcohol), dependence, and addiction are significant 
public health concerns. In 2003, 7.1% of Americans aged 12 or older were classified as 
current substance abusers. Statistically significant increases in the use of heroin, 
marijuana, cocaine, and pain relievers were reported from 2000 to 2001 (Substance 
Abuse and Mental Health Services Administration [SAMHSA], 2002). Furthermore, 17% 
of Americans reported lifetime substance abuse or dependence at some point. The highest 
prevalence rates of substance abuse have been reported (upwards of 90%) within inner-
city settings. One reason for this may be that inner-city individuals are likely to be 
exposed to substances more frequently than other subpopulations (Wallace, 2001).  
The consequences of this high prevalence of substance abuse represent an 
enormous cost to society. An estimated $484 billion is lost each year due to substance 
abuse-related costs, including crime, reduced job production, lost wages, health care 
expenditures, prevention, and treatment efforts (National Institute on Drug Abuse 
[NIDA], 2004). Furthermore, over $60 billion is spent on drugs annually, with $10 billion 
being spent on heroin, $35.2 billion on cocaine, $10.5 billion on marijuana, $15 billion 
on prescription drugs, and $5 billion on other illegal drugs (SAMHSA, 2002).  
Of current substance abusers in the United States, only 1.4% of them have sought 
some form of treatment for their drug or alcohol use. In particular, 1.2 million substance 
abusers receive treatment at an outpatient treatment facility, 752,000 at a 
residential/inpatient treatment facility, 729,000 at an outpatient mental health center, 
587,000 at a hospital as an inpatient, 377,000 at a private doctor’s office, 251,000 at an 
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emergency room, and 206,000 in prison or jail (SAMHSA, 2002). While treatment of 
substance abuse generally facilitates the recovery process compared to minimal or no 
treatment, a considerable number of addicted individuals relapse soon after treatment. 
Specifically, relapse rates during the year following treatment may be as high as 70% to 
80% (Ravndal & Vaglum, 2002; Simpson, Joe, & Brown, 1999, United States 
Department of Health and Human Services [USDHHS], 2005). 
In general, substance abuse treatment outcome studies have shown positive 
effects for a large number of substance users with regard to reduction in substance use, 
criminal activity, and improvement of psychological well-being (e.g., Guydish et al., 
1999; Hubbard et al., 1997). However, the high rates of relapse have compelled 
researchers to elucidate the factors that account for treatment success and failure, 
especially in regard to individual difference variables. Affect- and personality-related 
variables have been identified as focal targets of treatment, as they are considered to be 
associated with substance abuse. Studies have examined these variables as predictors of 
treatment outcome within methadone maintenance, outpatient, and residential substance 
abuse treatment programs (See Appendix A for additional detail regarding various 
settings for substance abuse treatment). However, the extent to which affect- and 
personality-related variables change during the course of treatment remains less well 
understood. The remaining sections of the introduction will outline the theoretical and 
clinical relevance of these predictors to substance abuse, followed by a review of studies 
that examine these variables as outcomes of treatment and the degree to which they 




Affect-Related Variables on Substance Abuse and Treatment Outcome 
Current work on substance abuse populations generally recognizes that affect-
related variables, such as negative affect, emotional states, anxiety sensitivity, and 
clinically-relevant symptoms of psychopathology work independently and together to 
constitute a vulnerability for substance abuse (Wise, 1988). A wide range of positive and 
negative psychophysiological effects including appetitive, aversive motivational systems, 
and affective states also have been associated with substance abuse (Correia, Carey, & 
Borsari, 2002; Hodgins, el-Guebaly, & Armstrong, 1995). Studies indicate that many 
substance abusers experience poor tolerance for unpleasant bodily sensations and 
negative emotional states which, consequently, may lead to continued substance use 
and/or increase risk for relapse to substance use following a period of abstinence. For 
example, studies have shown that positive affect and the experience of negative 
emotional events are associated with increased risk for substance dependence (Hull, 
Young, & Jouriles, 1986). In addition, Carpenter and Hasin (1999) demonstrated that 
relapsed alcohol-dependent patients often identify negative somatic and emotional states 
as causal factors in relapse, a finding consistently replicated in laboratory-based studies. 
For example, Cooney et al., (1997) found that negative affect enhanced the effects of 
alcohol cue presentation on the elicitation of alcohol urges and prediction of time to 
relapse.  
Recent efforts to investigate the role of interoceptive sensitivity and negative 
affect in substance abusing populations have adopted several constructs from the anxiety 
literature, namely anxiety sensitivity (Stewart, Samoluk, & MacDonald, 1999). Reiss 
(1991) described anxiety sensitivity as a tendency to respond fearfully to the occurrence 
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of symptoms of anxiety. Not only is anxiety sensitivity an important feature of several 
models of anxiety symptomatology (Reiss, 1991; 1997), but it is often associated with 
other psychological factors, such as negative emotionality (Lillienfeld, 1997) and 
depression (Taylor, Koch, Woody, & McLean, 1996).  
One assumption about anxiety sensitivity in the context of substance abuse is that 
drug use functions to attenuate fear, negative affect, and arousal sensations. Therefore, 
substances may be used to avoid or minimize the occurrence or recurrence of anxiety-
related symptoms (McNally, 1996; Stewart et al., 1999). Individuals who meet diagnostic 
criteria for substance abuse or dependence typically score significantly higher than 
average on anxiety sensitivity compared to nonclinical samples (e.g., Karp, 1993). In 
addition, anxiety sensitivity is predictive of frequency of drug and alcohol abuse 
(DeHaas, Calamari, & Blair, 2004).  
The levels of negative emotional states observed among substance abusers are far 
higher than the levels found in the general population (Clancy, 1997; Grisso, Davis, 
Vesselinov, Appelbaum, & Monahan, 2000; Reilly, Clark, Shopshire, Lewis, & Sorensen, 
1994; Reilly & Shopshire, 2000; Tivis, Parsons, & Nixon, 1998). Substance abusers 
administered the Spielberger State-Trait Anxiety Inventory (Grisso et al., 2000) typically 
have been shown to (a) have higher state and trait anxiety, (b) be more likely to express 
their feelings onto others, and (c) have less control of their feelings than controls 
(DeMoja & Spielberger, 1997). Consequently, reducing levels of negative emotional 
states is now seen as an important feature of recovery programs (see Appendix B for 
additional information regarding common approaches in residential treatments and issues 
related to treatment outcome). Marlatt (1985) emphasized the importance of emotional 
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states as triggers for relapse. He noted that 40% of relapses are related to emotional 
conflicts and associated states (e.g., anxiety and depression). A factor analysis of 
Marlatt’s relapse taxonomy using the Reasons for Drinking Questionnaire (Zywiak, 
Coonors, Maisto, & Westerberg, 1996) showed that the predominant factor was negative 
emotion. In turn, negative emotion was positively associated with alcohol dependence, 
trait anxiety, and depression (Zywiak, Coonors, Maisto, & Westerberg, 1996). Litt, 
Cooney, and Morse (2000) reported that substance abusers with urges to use drugs and 
alcohol had higher degrees of dependence, anxiety, and depression than those without 
such urges. 
Given the apparent centrality of negative affect, emotional states, and 
psychological symptomatology in the use of substances, the next logical step is to 
examine the role of these variables in treatment outcome and the malleability of the 
variables as a function of abstinence/treatment. One such study assessed experiential 
avoidance, controllability, anxiety sensitivity, and psychological symptoms in a 
residential substance-abusing sample (Forsyth, Parker, & Finlay, 2003). The authors 
recruited 94 predominantly male-veterans (96%) seeking substance use treatment at a 
Veterans Affairs Medical Center. Results found high anxiety sensitivity to be related to 
experiential avoidance, depression, and fears with bodily sensations associated with 
panic. In addition, high anxiety sensitivity was negatively correlated with general 
perceptions of controllability over anxiety-related events. Furthermore, patients who 
endorsed higher levels of anxious and depressive symptoms also reported greater 
tendencies to use emotional avoidance strategies and endorsed greater perceived 
uncontrollability. Post-treatment results revealed that improvement on the anxiety 
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sensitivity score was related to a decrease on anxious and depressive symptoms, as well 
as emotional distress. Findings from this study support the view that repeated use of 
substances are related to general emotional processes, negative affect, and a perceived 
inability to control one’s life. In addition, these findings are consistent with Alcoholics 
Anonymous (AA) programs and their recognition that the substance users’ life has 
become “unmanageable.” Essentially, the study provides information about control over 
specific emotional and physiological experiences that may exacerbate the tendency to 
abuse substances. These results also provide support for the assumption that experiential 
avoidance, controllability, anxiety sensitivity, and psychological variables related to 
engagement in substance abuse are amenable to change as a result of treatment.  
In a treatment research program, Guydish et al. (1998) conducted two studies to 
examine affect-variables as a predictor of treatment success across outpatient and 
residential substance abuse treatment. In the first study, individuals were assessed 2 
weeks to 6 months after treatment. A total of 1, 944 patients were admitted to the 
treatment center. Participants were excluded from the study if they were court mandated 
(n = 693), homeless (n = 495), or ineligible for random assignment based on clinical 
judgment (n = 222). In total, 534 patients were included and randomly assigned to 
outpatient or residential treatment. Both groups were compared at baseline to assess 
pretreatment differences. At baseline, patients were assessed on depression (assessed 
through the Beck Depression Inventory [BDI; Guydish, 1998]) and other psychological 
symptoms (e.g., negative affect). It was hypothesized that patients with higher baseline 
BDI scores and psychological symptoms would have worse treatment outcomes (e.g., 
treatment adherence and abstinence) than would subjects with lower scores. At post 
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treatment, outcome scores for both groups decreased by more than 50% after 1 month 
and remained at this level throughout the 6 month follow-up period. Further, residential 
patients reported greater gains than outpatients on psychological symptoms, including 
negative affect, but not on BDI scores. Individuals who evidenced a decrease on these 
variables reported a statistically significant improvement on treatment outcome variables. 
However, those whose BDI scores and psychological symptoms stayed constant fared 
worse. Although both groups evidenced significant changes on outcome scores from pre- 
to post-treatment, the fact that court mandated and homeless individuals were not 
included in this study warrants empirical scrutiny. Specifically, residential treatments 
often provide services to individuals under these circumstances (i.e., court ordered), 
therefore leaving the generalizability of these results questionable. 
The second study by Guydish et al. (1999) assessed these same individuals 18 
months after entering outpatient or residential substance abuse treatment. Residential and 
outpatient groups showed significant changes over time; however, between-group 
comparisons at post-treatment suggested that patients in residential treatment reported 
fewer psychiatric symptoms and significantly lower scores on depression. As noted, these 
results should be cautioned as the most problematic substance abusers were excluded 
from this study. Overall, the findings from this study suggest that patients assigned to 
outpatient or residential treatment do indeed reveal changes over time on outcome 
measures including psychiatric symptoms, BDI scores, and substance use. More 
importantly, these variables evidenced predictive power in terms of abstinence following 
treatment irrespective of treatment setting. It is noteworthy that treatment dropout during 
the first 2 weeks was lower in the residential treatment group, suggesting that this form of 
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treatment may be more effective in preventing relapse or more restrictive with regards to 
continuation of substance use.  
One recent study examined the role of depressive symptomatology in predicting 
drug abstinence at discharge from outpatient substance abuse treatment (Dodge, Sindelar, 
& Sinha, 2005). Data were collected from 827 patients admitted to the Yale University 
School of Medicine’s Substance Abuse Treatment Unit (SATU). Clinically significant 
levels of depressive symptoms, as per DSM-IV criteria were assessed upon treatment 
entry. In addition, participants were assessed on demographic (age, gender, ethnicity, 
education level, primary drug of use, and referral source) and treatment characteristics 
(i.e., length of time spent in treatment). Results suggested that higher depressive 
symptomatology scores significantly predicted a decreased likelihood of patients’ 
abstinence at discharge. Furthermore, these findings remained significant even after 
accounting for other significant demographic and treatment variables. Similar studies 
have found that higher levels of affect among substance abusers predicts worse treatment 
outcomes among cocaine users (e.g., Carroll et al., 1993; Wolpe et al., 1993), opiate 
addicts  (e.g., Kosten et al., 1986; Rounsaville et al., 1986), and alcoholics (Greenfield, 
1998; Hasin, 2002). Overall, these data indicate that affect variables are an important 
factor for shaping successful substance abuse treatment outcomes.  
In addition to studies that have evidenced affect-related variables as a predictor of 
treatment success (Guydish et al., 1998, 1999), a number of large-scale treatment 
outcome studies supported by National Institute on Drug Abuse (NIDA) found affect 
variables themselves to change throughout treatment. For example, Gossop, Marsden, 
Stewart, and Kidd (2003) reported 5-year outcomes from patients in the National 
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Treatment Outcome Research Study (NTORS). Four broad treatment modalities 
including inpatient, residential, methadone maintenance, and methadone reduction 
programs were studied. Results indicated that levels of anxiety and depression were 
reduced by 45% when compared to scores at intake in all groups. Additionally, across 
groups there were also statistically significant reductions in reported crime (e.g., drug-
selling, arrests) between intake and follow-up. Overall, these data suggest that each of the 
four treatment types resulted in significant reductions in anxiety, depression, drug use, 
and engagement in crime-related incidents. However, no indication of the degree to 
which change in mood variables relate to substance abuse treatment success was 
provided. Specifically, no information was given regarding how much of the variance 
each of these variables accounted for in treatment success. The Drug Abuse Reporting 
Program (DARP), another NIDA-supported study, was designed to assess patients 
entering drug abuse treatment. Data were collected on 44,000 patients across the 
following treatment conditions: methadone maintenance, outpatient drug free, and long-
term residential programs. Follow-up sessions occurred at 1 to 5 years post treatment. 
Results suggested that, despite the type of treatment setting, patients had statistically 
significant reductions in psychological symptoms, and levels of heroin use and other 
illicit drug use. Specifically, scores on psychological profile (including affect) and 
incidents of drug-related crime were found to decline during treatment and remained 
lower than baseline scores at post-treatment (Hubbard et al., 1997). Overall, data from 
DARP indicated that each of the three treatment types resulted in improvements on 
psychological symptoms, reductions in drug use, and involvement in criminal activities. 
Thus, in addition to improving levels of psychopathology, this study provides evidence of 
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the effectiveness of substance abuse treatment in interrupting early criminal behaviors 
and drug abuse (Hubbard et al., 1997).  
On the basis of this review, there are compelling data regarding the singular, as 
well as joint influence, of affect-related variables on engagement and success in 
substance abuse treatment in general (Anglin et al., 1997; Hubbard et al., 1997; Zhiwei, 
Friedmann, & Gerstein, 2003). As such, these variables have been examined as predictors 
of treatment and have demonstrated noticeable changes over the course of treatment. For 
example, positive change scores on anxiety sensitivity were indicative of improvement on 
depressive and anxiety symptoms. Also, a decrease in anxiety symptoms and depression 
measures, as well as decrease in criminal activities and drug use irrespective of treatment 
setting was revealed. One question that cannot be addressed by this review is whether 
change in affect-related variables is necessary for the substance abuse change (i.e., 
mediator) or affect-related variables change as a function of and therefore subsequently to 
relapse, both of which are beyond the scope of this paper. In addition to state-level affect 
changes, we now outline the role of personality-related variables across the disinhibition 
spectrum (i.e., impulsivity and risk-taking propensity) and their relationship to substance 
abuse (Bickel, 1999; Depue & Collins, 1999; Eysenck & Eysenck, 1977; Lejuez et al., 
2002; Lejuez, Simmons, Aklin, Daughters, & Dvir, 2004; Sher et al., 1999). A review of 
these variables and the changeability of these patterns during treatment will follow.  
 
Personality-Related Variables on Substance Abuse and Treatment Outcome 
Researchers and clinicians have long adhered to the belief that personality-related 
variables, particularly those along the trait-disinhibition continuum, play an important 
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role in engagement in substance abuse (Aklin, Lejuez, Zvolensky, Kahler, & Gwadz, 
2005; Eysenck, Pearson, Easting, & Allsopp, 1985; Krueger et al., 2002; Lejuez, Aklin, 
Bornovalova, & Moolchan, 2005; Sher, Bartholow, & Wood, 2000). Specifically, these 
determinants of trait-disinhibition have been found to be composed of several constructs, 
as indexed by self-report and laboratory tasks, including impulsivity and risk-taking 
propensity (Sher et al., 2000). Although several definitions of impulsivity have been 
proposed in the literature, it is commonly referred to as the tendency to enter into 
situations or rapidly respond to cues for potential reward without much planning or 
deliberation and without consideration of potential punishment (Eysenck, Pearson, 
Easting, & Allsopp, 1985). Risk-taking involves one’s decision to engage in a particular 
behavior resulting in a balanced probability of positive or negative consequences (Jessor, 
1998; Leigh, 1999).  Although risk-taking has been found to share common 
characteristics between impulsivity and other static personality traits (i.e., sensation 
seeking), risk-taking propensity is discernable (Eysenck & Eysenck, 1977; Wills, Sandy, 
& Yaeger, 2002; Zuckerman, 1991; Zuckerman & Kuhlman, 2000). For example, 
research indicates a positive feedback loop such that engagement in risky behaviors may 
affect current levels of these variables. That is, engaging in substance use may, through 
processes such as pharmacological influences, make an individual more disinhibited and 
thus more likely to engage in high risk behaviors (e.g., Pogge, Stokes, & Harvey, 1992).   
The decision to engage in a particular risk taking behavior, though often well 
characterized by impulsivity and/or sensation seeking, at times may not be well 
characterized by these variables. For example, one could decide to engage in substance 
use with limited forethought or planning. Alternatively, one could decide to use 
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substances with much thought going into the decision. In this way, risk-taking propensity 
may be less of a single construct and more of a larger construct including a variety of 
other factors (Lejuez, Aklin, Bornovalova, & Moolchan, 2005). 
Taken together, disinhibition represents a multidimensional construct that has 
been proposed to underlie the propensity to engage in substance use and is thought to 
have a biological, largely heritable basis.  For example, the tendency for some individuals 
to persistently search for highly stimulating experiences has been attributed to a low 
activation of the behavioral inhibition system, experienced as a relatively low level of 
anticipatory anxiety (Fowles, 1980; Gray, 1982; Hare, 1978; Zuckerman, 1983). 
Similarly, others have noted that impulsivity and risk propensity are indicators of a core 
neurobiological process; namely, the underlying approach/avoidance system oriented 
toward engagement in hedonic behavior (Depue & Collins, 1999; Gray, 1987; 
Zuckerman, 1991; Zuckerman & Kuhlman, 2000). Others have rejected the theory that 
trait-personality variables form the primary basis for engagement in substance abuse, but 
rather they propose that it is the interaction between personality and environmental 
variables that is of primary importance (e.g., Nathan, 1988). Regardless of which 
etiological bent is operative, studies have documented a relationship between components 
of disinhibition (i.e. impulsivity, risk-taking propensity) and substance abuse (Krueger et 
al., 2002; Lejuez et al., 2002; Sher, Bartholow, & Wood, 2000; Tarter et al., 2003; 
Zuckerman et al., 1988). 
Traditionally, researchers have assessed levels of disinhibition using self-report 
measures; however, the exclusive reliance on self-reports has several limitations, 
including failure to report one’s own behavior accurately, potentially due to lack of 
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insight and/or cognitive ability on the part of the respondent. Another method for 
capturing disinhibition is through behavioral laboratory tasks. Although there are several 
types of behavioral laboratory measures, one measure of disinhibition involves the choice 
of a smaller immediate reward over a larger delayed reward (also referred to as delayed 
discounting). In these types of behavioral laboratory tasks, choosing the smaller 
immediate reward is considered to be an impulsive choice (Bickel, Kirby, Petry, & 
Bickel, 1999; Madden et al., 1997; Mitchell, 1999; Vuchinich, 1998). Using a delay 
discounting laboratory measure of impulsivity, Kirby, Petry, and Bickel, (1999) 
compared 50 subjects with heroin dependence and 60 healthy controls. They found that 
the tendency to discount the value of delayed rewards for heroin-dependent subjects was 
twice the rate in controls. Furthermore, the rate of discounting was positively correlated 
with impulsivity as measured by self-report questionnaires. In another study of alcohol-
dependent subjects and controls, Petry (2001) used a delayed-reward laboratory measure 
of impulsivity to compare currently using alcohol-dependent subjects, abstinent alcohol-
dependent subjects, and healthy controls. Alcohol-dependent subjects were shown to be 
more impulsive than controls, and within alcohol-dependent subjects, those who achieved 
abstinence were less impulsive than active users. A third study using delayed-reward 
measures in subjects with a history of substance abuse and controls found that individuals 
with a history of substance abuse were less able to tolerate delays for a longer reward 
(Allen, Moeller, & Rhoades, 1998). 
As an alternative measure of disinhibition, researchers have begun to develop and 
utilize tasks that simulate situations under which real-world risk behaviors may occur 
(e.g., Allen, Moeller, Rhoades, & Cherek, 1998; Bickel, Odum, & Madden, 1999; Crean, 
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de Wit, & Richards, 2000; Mitchell, 1999; Vuchinich & Simpson, 1998). One such tool is 
the Balloon Analogue Risk Task (BART; Lejuez et al., 2002). The BART involves the 
inflation of a computer-simulated balloon, with greater balloon inflation associated with 
greater reward, under the contingency that at some point the balloon will explode and any 
accrued reward for that balloon is eliminated. Therefore, in deciding how much to inflate 
each balloon, participants must balance potential gain against potential risk. Riskiness on 
the BART was shown to be related to engagement in substance use in both adults (Lejuez 
et al., 2002; Lejuez et al., 2004) and adolescents (Aklin, Lejuez, Zvolensky, Kahler, & 
Gwadz, 2005; Lejuez, Aklin, Zvolensky, & Pedulla, 2002). Further, the relationship of 
the BART and the real-world risk-taking behaviors was evident even after controlling for 
other self-reported disinhibition variables, including impulsivity and sensation seeking.  
More recently, Lejuez and colleagues have conducted a series of studies 
examining disinhibition and substance abuse on both a general level and across drug 
classes among inner-city substance abusers (Bornovalova, Daughters, Hernandez, 
Richards, & Lejuez, in press; Lejuez, Simmons, Aklin, Daughters, & Dvir, 2004). In a 
preliminary investigation, Lejuez et al., (2004), examined the relationship between risk-
taking propensity and risky sexual behavior (e.g., exchange sex for drugs, sex without a 
condom) in a sample of treatment seeking drug users. Participants included 76 inner-city 
substance users, who were assessed on levels of sexual risk, impulsivity, depression, self-
esteem, and risk propensity as indexed by the BART. Results indicated that impulsivity, 
self-esteem, and risk propensity were independently related to risky sexual behavior. 
Furthermore, risk propensity evidenced incremental validity above and beyond that 
provided by demographic variables, impulsivity, self-esteem, and depression. Prior to this 
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study, researchers have not integrated a behavioral assessment measure to tap 
disinhibition among inner-city substance abusers. Although Lejuez and colleagues did 
not assess substance use patterns specifically, other studies have indicated that substance 
use is associated with engagement in various sexual risk behaviors, including the 
exchange of sex for drugs (e.g., Bux et al., 1995; Camacho et al., 1997; Grella et al., 
1995; Joe & Simpson, 1995). Additionally, while Lejuez et al., (2004) provide important 
results among a unique sample of substance abusers, participants were only assessed at 
one time point. Therefore, information about the extent to which levels of disinhibition as 
indexed by behavioral tasks, change as a function of treatment cannot be gleaned from 
these findings.  
Taking a more focused approach to risk propensity and substance abuse, 
Bornovalova, Daughters, Hernandez, Richards, and Lejuez (in press) examined 
differences between risk propensity and impulsivity among primary users of 
crack/cocaine and heroin users. Specifically, individuals who were primary users of 
either crack/cocaine or heroin (i.e., use of the drug at least 2-3 times per week over the 
past year), and not primary users of the other drug (i.e., use of the drug less than once per 
month over the past year) were included in the study. Risk-taking propensity was 
assessed using the BART and impulsivity using the Delayed Discounting Task. Initial 
results indicated that crack/cocaine users were significantly more risky and impulsive 
than heroin users, despite the absence of acute drug effects. After controlling for age and 
gender, the difference in the two groups remained significant for the Delayed 
Discounting Task, but was reduced to non-significant for the BART.  
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Despite these encouraging findings that indicate a significant association between 
trait-disinhibition and substance abuse, no studies have examined these variables as 
predictors of treatment outcome, as well as investigated the changeability of these 
predictors throughout substance abuse treatment. Because personality variables are often 
considered to be long standing patterns of behavior, this may be why they have not been 
examined in this way. Therefore, the extent to which disinhibition variables are amenable 
to change as a function of substance abuse treatment has not yet been documented.  
 
Theoretical Implications across Affect- and Personality-Related Dimensions 
Understanding changes in affect- and personality variables among substance 
abusers would be beneficial in terms of prevention and treatment development efforts. 
However, to truly understand this relationship, it is important to first highlight potential 
theoretical frameworks that may guide this work. The most widely accepted framework 
comes from the social-cognitive model developed by Bandura (1994). The social 
cognitive model explains how individuals acquire and maintain certain behavioral 
patterns, while also providing the basis for intervention strategies. Thus, evaluating 
behavior change depends on factors such as environment and one’s behavior. The major 
thrust of the model centers on awareness and knowledge of substance abuse and their 
resulting behaviors are fundamental principles for control and behavior change. Yet, a 
number of studies have shown that dissemination of information alone is rather limited in 
preventing or reducing substance abuse (Kar, 2001; Kelly & Kalichman, 2002). In 
addition to providing information to facilitate change, it also seems critical to have the 
behavioral means, resources, and social supports (i.e., Bandura, 1994). Above and 
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beyond behavioral capabilities and resources, there is a sizable gap between simply 
possessing self-regulatory skills and being able to use them effectively under difficult 
circumstances, which requires belief in one's efficacy to exercise personal or impulse 
control. The sense of personal control or perceived self-efficacy often stems from past 
positive and/or negative consequences of coping with life stressors. Thus, in guiding 
one’s behavior, self-regulatory skills, including affective reactions to one's own conduct 
are important constructs to consider. Such skills will determine the potential situations in 
which an individual may find the necessary skills to resist social pressures and 
engagement in substance use that will lead to behavior change.  
In examining Bandura’s model with more specific attention to affect- and 
personality variables and their relationship to engagement in substance use, several 
important variables emerge. Namely, factors such as impulsivity, risk-taking propensity, 
and level of pathology all have been found to contribute to the theoretical understanding 
of substance abuse. There is an empirical link between each of these variables (Ravndal 
& Vaglum, 2002; Simpson, Joe, & Brown, 1999). 
 
Sample-Related Issues 
In beginning to target the understanding of how personality-related variables may 
or may not change in the course of treatment, it is crucial to be clear about the type of 
treatment and setting of interest. Although several options could represent a starting 
point, researchers have identified inner-city substance users in residential treatment as 
being especially vulnerable to relapse following substance abuse treatment (e.g., Ravndal 
& Vaglum, 2002; Simpson, Joe, & Brown, 1999; Stark, 1992). Perhaps because this 
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patient group is often exposed to high risk situations and environments is reason to 
believe why this subpopulation is most susceptible for engaging in such behaviors (Kral 
et al., 1998). Although research indicates that impulsivity and risk taking may be related 
to substance use at a more general level, more recent work indicates that these 
relationships differ across drug classes. Most of this work, however, has focused 
primarily on crack and heroin use together and less attention to other drug classes 
(Avants, Marcotte, Arnold, & Margolin, 2003; DHHS, 2003; Ensminger, Anthony, & 
McCord, 1997).  
Indeed, participation in substance abuse treatment is generally associated with a 
reduction in substance use and high risk resulting behaviors (e.g., unsafe sex, sharing 
needles; Sorensen & Copeland, 2000). However, inner-city settings remain a grossly 
underserved population. Only a few studies, conducted by our center, have examined the 
potential relevance of affect and disinhibition variables to inner-city substance users in 
residential treatment (e.g., Bornovalova, Daughters, Hernandez, Richards, & Lejuez, in 
press; Daughters, Lejuez, Kahler, Strong, & Brown, 2005; Lejuez et al., 2004). Generally 
speaking, inner-city substance abusers have been found to be significantly more risky and 
impulsive than other sub-groups of substances abusers (Bornovalova et al., in press). 
Unanswered questions remain regarding the relationship of affect- and personality-related 
variables as predictors of treatment outcome and the changeability of these variables 
throughout the course of treatment exclusively with inner-city, substance-using samples. 
Future studies should discern the extent to which tailoring substance abuse treatments to 




Statement of the Problem 
Despite widespread advances in assessment and treatment domains, substance use 
(e.g., drug, alcohol), dependence, and addiction continue to be prevalent problems that 
compromise health, quality of life, and cost to society (Harwood, 2000). A great deal of 
research over the past three decades has focused on developing and evaluating treatments 
for substance abuse. Although treatment facilitates abstinence for a number of individuals 
(e.g, Gossop, Marsden, Stewart, & Treacy, 2002), many patients often relapse soon after 
treatment (Ravndal & Vaglum, 2002; Simpson, Joe, & Brown, 1999). Inner-city 
substance users are an underserved group that experience greater levels of substance 
abuse, and are thereby at a heightened risk for treatment failure (i.e., relapse) than other 
subpopulations (Avants, et al, 2003; DHHS, 2003; Ensminger, et al, 1997). Despite the 
clinical enthusiasm and promise of preliminary studies with community-based programs 
for substance users (Anglin et al., 1997; Hubbard et al., 1997; Zhiwei, Friedmann, & 
Gerstein, 2003), future research must investigate how to improve retention and identify 
the mechanisms of change occur during treatment, as well as adequate ways to measure 
them. The current study represents a first step in an attempt to disentangle factors that are 
amenable to change during treatment, thus setting the stage to begin to examine the 
changeability of affect and personality variables throughout the course of treatment.  
 
Chapter 2: Rationale for the Current Study and Design Overview 
The extant literature indicates a substantial association between affect-and 
personality-related variables and substance abuse. However, evidence supporting these 
predictors as outcomes and the degree to which they change as a function of substance 
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abuse treatment points toward affect-related variables, as there have been no studies 
examining this with personality-related variables. Of the studies that have examined 
affect-related variables as treatment outcome variables within a residential setting, most 
typically exclude problematic patients (e.g., Guydish et al., 1998, 1999). Excluding these 
individuals reduces the generalizability of these studies. Furthermore, residential 
substance abuse treatments are likely to be the most intensive form of treatment and often 
the last option in place of incarceration. As such, residential treatment programs are 
likely to accommodate the most problematic patient groups, including those who are 
court referred, have high levels of substance use severity, or report high levels of negative 
affect and trait-disinhibition. For these reasons, it is important to examine the extent to 
which affect-and personality-related variables change during the course of residential 
substance abuse treatment. Accordingly, the current study examined the impact of 
residential substance abuse treatment on affect- and personality-related variables with 
inner-city substance abusers over a 30-day course of treatment. It is important to note that 
the current study did not examine relapse following treatment, given the overarching 
focus to explore changes that occur during treatment. Thus, these data may be used to 
develop more elaborate future studies that examine changes mediating attrition and 
subsequent relapse. To assess changes on affect- and personality-related variables while 
simultaneously eliminating systematic order effects due to the repeated administration of 
measures, participants were separated into 2 groups. Specifically, the first was assessed at 
pre- and post-treatment and the second only at post-treatment (see Procedures for detailed 
information regarding groups). Irrespective of the group status, participants were 
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compared on demographic information to permit more confidence that our results were 
attributed to the influence of treatment, as opposed to pre-testing on the measures.  
 
Chapter 3: Method of the Current Study 
Participants  
The current sample included 81 adults between the ages of 18-56 years, sampled 
from consecutive admissions at the Salvation Army Harbor Lights residential drug 
treatment facility located in Northeast Washington, DC. Demographic data for the 
proposed study was similar to previous studies conducted at the site (e.g., Lejuez et al., 
2004). In particular, the sample was two-thirds male, 90% African American, average age 
was in the late 30’s, and on average, most only had a high school education. Participants 
were recruited when they first enrolled at the treatment facility. Each participant was 
asked if they would like to participate in a study examining changes in behavior and 
personality. The only exclusionary criterion was psychosis, although variables such as 
psychological disorders and medications prescribed were assessed and addressed 
statistically as appropriate. Participants were told that involvement in the study was 
completely voluntary and would not affect their status at the facility should they refuse 
participation (center staff do not have access to such information). More detailed 
recruitment information is provided below. 
 
Residential Treatment Facility 
The Salvation Army Harbor Lights residential substance abuse treatment facility is a 
public, non-profit, 64-bed inpatient center that serves adult men and women with 
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substance abuse dependence (e.g., alcohol, marijuana, cocaine, and heroin). Individuals 
who request treatment often are referred from various sources, including legal services 
(i.e., court-mandated, probation/parole), community shelters, social services, and self-
referrals. During the initial phase, before being admitted into the treatment facility, 
patients are required to undergo detoxification lasting between 7 to 21 days. Treatment at 
the center involves sessions focused on functional analysis, as well as a variety of 
strategies adopted from Alcoholics Anonymous and Narcotics Anonymous. In addition to 
didactic lectures, sessions are provided in individual and group format within a full day, 
seven days a week. Medication assessment and monitoring is provided for patients 
throughout the course of treatment for conditions requiring such attention (e.g., 
psychological, medical). Treatment contracts typically are 30, 90, and 180 days. The 
center requires complete abstinence from drugs and alcohol, with the exception of 
caffeine and nicotine; weekly drug testing is mandatory and any use is grounds for 
dismissal. Aside from scheduled activities (e.g., group retreats, physician visits), residents 
are not permitted to leave the center grounds during treatment. During the final stages of 
the residential program, the focus shifts outward, supporting the patient to make 
independent employment and living arrangements. Therefore, in aftercare, patients no 
longer live in the residential setting but participate in individual and group therapy on an 
outpatient schedule. The training level of staff at the program includes a range of doctoral 
and master’s level clinicians and substance counselors (information about the type of 






Assessment sessions occurred twice per week in a meeting room at the Salvation 
Army Harbor Lights Treatment facility. The Center Director granted permission to access 
patients every Tuesday and Friday until completion of the study. Previous studies 
conducted at the facility over the past three years have been very successful with regard 
to recruitment. To date, Dr. Lejuez’s Center has successfully recruited over 800 subjects 
across 8 studies with less than 5% declining participation.  
The initial assessment session for participants occurred on either the first Tuesday 
or Friday during a 3-day window (i.e., 4rd, 5th or 6th day at the center). Assessments did 
not take place until a patient’s 4th day in the center largely because patients tended to be 
inundated with forms and other standard in-take procedures at the center. Specifically, 
combined with required off-site detoxification prior to entering the center on an as 
needed basis, this time frame allowed adequate time for acclimation to the center and to 
further ensure that the patient’s acute withdrawal symptoms had subsided.  
All participants began by providing informed consent and completed a basic 
demographics form, including a thorough description of the study. Specifically, the form 
explained that all participants will first be paid $5 for completing a basic demographic 
form, followed by assignment to 1 of 2 groups. Participants were assigned, on an 
alternating basis across two groups. Those assigned to the pre-post group continued to 
participate for an additional hour to complete self-report and behavioral measures 
indexing their drug use history, personality characteristics, and mood states. Participants 
in the pre-post group received an additional $20 at the end of this session. They also were 
informed that they would be asked to complete the same measures 30 days later and 
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could earn up to an additional $20 (a total of $45). However, if assigned to the post only 
group, they would only need to complete a demographic questionnaire and then will be 
finished for the day, but would be expected to complete the same assessment as the pre-
post group in 30 days where they could earn up to $20 (a total of $25).  
Pre-Post Group. Upon entry into the study, 41 participants assigned to the pre-
post group completed a battery of 7 questionnaires to assess demographics, impulsivity, 
depressive and anxiety-related symptomatology, experiential avoidance, drug use history, 
and behavioral measures including delayed discounting and the Balloon Analogue Risk 
Task. All measures were administered in random order. As participants completed 
questionnaires, individuals who were trained in administering the behavioral task 
accompanied participants one by one to an adjacent room to complete the task. To ensure 
that participants had incentive to perform their best, they were told that the better they 
perform on the behavioral tasks the more money they would earn. A member of our 
research team was made available at all times to answer any questions.  
After participants completed questionnaires and the behavioral tasks, they were 
told the amount of money they have won and asked to sign a receipt. Money earned from 
the study was deposited in the participants account at the facility on the next business 
day. Each session lasted no more than 60 minutes. They were paid between $10 and $20 
depending on their performance on the behavioral task (total score). Study participants 
were reassessed on either of their last 3 days of treatment (i.e., 28th, 29th or 30th day at the 
center), which they completed the same procedures and payment (between $10 and $20 
based on their performance). 
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Post-Only Group. Participation for the post-only group was exactly the same as 
the 30-day reassessment given to the pre-post group. Specifically, 40 participants 
received demographics at pre-treatment and the remaining questionnaires at post-
treatment. Of note, these data allowed pretreatment comparisons of individuals from both 
groups and eliminate systematic order effects due to the repeated administration of 
questionnaires and behavioral tasks.  
 
Questionnaires 
Participants completed a variety of questionnaires examining the extent to which 
levels of anxious and depressive symptomatology and measures of disinhibition variables 
change as a function of continuation in residential drug treatment. 
Demographics. To measure and account for individual differences, participants 
provided basic demographic information including age, gender, education level, 
occupation, home occupants, and socioeconomic status. A copy of the demographics 
form is listed in Appendix D. 
Acceptance and Action Questionnaire (AAQ; Hayes et al., 2002). The AAQ is a 
22-item measure that assesses experiential avoidance, or the tendency to avoid or alter 
unwanted internal experiences, primarily in the form of emotions. Participants rated the 
degree to which each statement applied to them using a 7-point Likert scale (0 = never 
true to 7 = always true). Higher AAQ scores correspond to high experientially avoidant 
tendencies. There is evidence for the convergent and divergent validity of the AAQ as 
well as adequate internal consistency (α = .70; Hayes et al., 1996). Good test-retest 
reliability (r = .85) over a 30-week interval was reported for the AAQ. Further 
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establishing its psychometric properties, Forsyth et al., (2002) found that the alpha 
coefficients ranged from .88 to .90. Internal consistency of the AAQ in this sample was 
good (α = .74). The AAQ is listed in Appendix E. 
State-Trait Anxiety Inventory (STAI; Speilberger, Gorsuch, & Lushene, 1983). 
The STAI is a 40-item measure used to assess state and trait anxiety. The state scale 
measures the more transient anxiety experienced in a specific immediate situation 
(Speilberger, Gorsuch, & Lushene, 1983), whereas the trait scale measures individual 
differences in the perception of stress and in the overall pattern of responses to stressful 
or anxiety provoking situations. The STAI has been well validated in a variety of 
populations, including substance users (Donham & Ludenia, 1984). Internal consistency 
of the state scale in the current study was adequate (α = .69) and poor for the trait scale (α 
= .60). In addition, evidence of construct and concurrent validity has been established. A 
copy of the STAI is given in Appendix F. 
Center for Epidemiological Studies – Depression Scale (CES-D; Radloff, 1977). 
This scale was used to assess differences in depressive symptoms. The CES-D is a 22-
item self-report inventory designed to measure current depressive symptomatology in the 
general population. This scale was designed for use in non-psychiatric settings and was 
therefore appropriate for assessing the depressive symptoms of this population. The focus 
of the scale is on affective components of depressive symptomatology and includes 
depressed mood, feelings of guilt and worthlessness, feelings or helplessness and 
hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance. High 
internal consistency has been demonstrated in general (Chronbach’s α = .85) and patient 
(Chronbach’s α = .90) samples. Six-month test-retest reliability on individuals reporting 
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no negative life events was adequate (r = .54). Discriminant validity was high between 
psychiatric inpatients and the general population (Radloff, 1977). Additionally, this 
measure correlates strongly (r =.87) with the Beck Depression Inventory (Santor et al., 
1995). The alpha coefficient for the CES-D in the current study was acceptable (α =.76). 
Refer to Appendix G for a copy of the CES-D. 
Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 
1988). This 20-item measure was used to assess differences in positive and negative 
mood. The scale assesses both positive (PA) and negative (NA) affect. PA is the extent to 
which a person feels enthusiastic, alert, and active. NA is the extent to which a person’s 
subjective distress is characterized by a number of negative mood states including anger, 
contempt, distrust, and guilt. NA is related to self-reported stress and poor coping (Clark 
& Watson, 1988) and frequency of unpleasant events (Stone, 1981). The correlation 
between the two scales is low (r = -.12 to -.23), suggesting that the two scales measure 
independent constructs and thus, can be examined separately. It has also shown strong 
discriminant and convergent validity, indicating the measure is sufficiently discriminable 
from related constructs such as depression and state anxiety (Watson, 1988). Internal 
consistency of the PANAS in the current study was good (α = .70). Refer to Appendix H 
for a copy of the PANAS.   
Delay Discounting Procedure (Kirby & Marakovic, 1996; Monterosso et al., 
2001). Delay discounting refers to the degree to which an individual shows preference for 
either small, readily available rewards or larger, delayed rewards. This procedure is a 
paper-and-pencil version of the original monetary-choice questionnaire (Kirby & 
Marakovic, 1996) that has extensively been used in research on sensation-seeking, 
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impulsivity, and risk-taking, and has been found to correlate highly with other behavioral 
measures of impulsivity (Monterosso et al., 2001; Madden et al., 1997). This measure 
consists of a fixed set of 27 choices between smaller, immediate rewards and larger 
delayed rewards. For example, “Would you prefer $54 today OR $55 in 117 days?” The 
presentation order is contrived to not correlate choice amounts, ratios, differences, delays 
or discount-rates implied by indifference to the two rewards. From the responses an 
estimate “k” is derived to indicate level of impulsivity. Detailed information about the 
DDP is provided in the behavioral task section. A copy of the Delay Discounting 
Procedure is listed in Appendix I.  
Drug Use Questionnaire (DUQ; Grant, Contoreggi, & London, 2000). To assess 
polysubstance use, the DUQ was administered. Specifically, participants were asked if 
they have ever used a particular drug in their lifetime, how often they used it in the past 
year prior to treatment, and how often they used the drug during the period of their life 
when they were using it most frequently. Participants answered the latter two questions 
on a 6-point scale ranging from “never”, “one time”, “monthly or less”, “2 to 4 times a 
month”, “2 to 3 times a week”, and “4 or more times a week.” The drug categories 
included: (a) cannabis, (b) alcohol, (c) cocaine, (d) MDMA, (e) stimulants, (f) sedatives, 
(g) opiates, (h) hallucinogens (other than PCP), (i) PCP, (j) inhalants, (k) and nicotine. 
Refer to Appendix J for a copy of the DUQ.  
Eysenck Impulsivity Scale (EIS; Eysenck, Pearson, Easting, & Allsopp, 1985). 
The EIS is a 54-item forced choice measure that taps impulsiveness (19 items), 
venturesomeness (similar to sensation seeking; 16 items), and empathy (19 items). For 
each of these three scales, items were scored dichotomously with higher scores indicating 
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greater endorsement of the construct. The empathy subscale consists of items that are 
unrelated to risk and will be examined in the present study as an index of discriminant 
validity. Eysenck et al. (1985) found that the alpha coefficients were .84, .85, and .69 for 
impulsiveness, venturesomeness, and empathy, respectively. Furthermore, alpha 
coefficients for males have been reported .84, .85, and .69 for impulsiveness, 
venturesomeness, and empathy, respectively; and females .83, .84, and .69 for 
impulsiveness, venturesomeness, and empathy, respectively; Eysenck et al. 1985. Internal 
consistency of this scale in the current study was acceptable (α = .72). A copy of the EIS 
is given in Appendix K. 
 Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004), is a 36-
item, self-report measure that assesses individuals’ typical levels of difficulties in 
emotion regulation. Participants rated each item using a 5-point Likert scale (1 = almost 
never, 5 = almost always) based upon the extent to which it corresponds with how they 
respond to uncomfortable emotional experiences. The DERS provides a total score 
representing overall difficulties in emotion regulation, as well as 6 subscale scores: (a) 
non-acceptance of emotional responses, (b) difficulty engaging in goal-directed behavior 
when distressed, (c) impulse control difficulties when distressed, (d) lack of awareness of 
emotions, (e) limited access to strategies for regulation, and (f) lack of emotional clarity. 
The DERS has been found to have adequate construct and predictive validity and good 
test-retest reliability over a period of 4 to 8 weeks (ρI = .88; Gratz & Roemer, 2004). The 
DERS also has been found to be negatively correlated with an experimental measure of 
emotion regulation (assessed as willingness to experience distress in order to pursue goal-
directed behavior) within a clinical population (r = -.63; Gratz, Rosenthal, Tull, Lejuez, 
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& Gunderson, in press). Higher scores correspond to greater difficulties. Internal 
consistency of this scale in the current study was excellent (α = .80).  
 
Behavioral Tasks 
The behavioral tasks were used to assess levels of impulsivity and risk propensity. 
Participants completed the BART and Delayed Discounting Task. A description of both 
tasks is provided below:  
Balloon Analogue Risk Task (BART; Lejuez et al., 2002). To assess impulsive-
risk-taking propensity, the BART was administered. This measure has been used 
successfully to describe currently occurring risk behaviors in young adults (Lejuez et al., 
in press; 2002) and middle adolescents (Aklin, Lejuez, Zvolensky, Kahler, & Gwadz, 
2005; Lejuez, Aklin, Zvolensky, & Pedulla, 2003). In this task, the BART was presented 
on the computer in the classroom. Specifically, the computer screen displayed a small 
simulated balloon accompanied by a balloon pump, a reset button labeled “Collect $$$,” 
a permanent money earned display labeled “Total Earned.” Participants were then 
directed to pump the simulated balloon to earn as much money as possible, taking into 
consideration that the balloon can pop at any time. Each click on the pump inflated the 
balloon one degree (about .125” in all directions). With each pump, 2 cents was 
accumulated in a temporary bank (this amount was indicated to the participant). 
Participants were told the optimal number of pumps for each balloon was 64 pumps. 
After a balloon is pumped past its individual explosion point, a “pop” sound effect 
generated from the computer. When a balloon exploded, all money in the temporary bank 
was lost and the next uninflated balloon appeared on the screen.   
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At any point during each balloon trail, the participant had the opportunity to stop 
pumping the balloon and click the “Collect $$$” button. Clicking this button transferred 
all money from the temporary bank to the permanent bank, during which the new total 
earned incrementally updated cent by cent while a slot machine payoff sound effect 
played. After each balloon explosion or money collection, the participant’s exposure to 
that balloon ended, and a new balloon appeared until a total of 20 balloons (i.e., trials) 
were completed. These 20 trials were comprised of different balloon types, all with the 
same probability of exploding. Participants were not given any detailed information about 
the probability of an explosion, but instead told that the best strategy would be to pump 
each balloon 64 times. They were also told that at some point each balloon will explode 
and this explosion could occur as early as the first pump all the way up to the point at 
which the balloon expands as large as the computer screen (see instructions below). The 
probability that a balloon will explode is arranged by constructing an array of N numbers. 
The number “1” is designated as indicating a balloon explosion. With each pump of the 
balloon, a number was selected without replacement from the array. The balloon 
explodes if the number 1 is selected. For this experiment N equaled 128. Thus, the 
probability that the balloon exploded on the first pump was 1/128. If the balloon did not 
explode after the first pump, the probability that the balloon exploded was then 1/127 on 
the second pump, 1/126 on the third pump and so on up until the 128th pump at which the 
probability of an explosion will be 1/1 (i.e., 100%).  
According to this algorithm, the average breakpoint is 64 pumps. Modeling real-
world situations in which excessive risk often produces diminishing returns and 
increasing threats to one’s health and safety, each successive pump on any particular 
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balloon trial (a) increases the amount to be lost due to an explosion and (b) decreases the 
relative gain of any additional pump. For example, after the first pump the next pump 
risks only the 2 cents accrued in the temporary bank and would increase the possible 
earnings on that balloon by 100%, yet after the 20th pump, the next pump risks 3 dollars 
accrued in the temporary bank and would increase possible earnings on that balloon trial 
only by 1.6%.  
Prior to starting the BART, the experimenter thoroughly explained the task 
accompanied by the following directions: 
Throughout the task, you will be presented with a number of 
balloons, one at a time. For each balloon you can click on the 
button labeled "Press This Button to Pump Up the Balloon" to 
increase the size of the balloon. You will accumulate 2 cents in a 
temporary bank for each pump. Although the amount per pump 
will be shown, you will not be shown the amount you have 
accumulated in your temporary bank. At any point, you can stop 
pumping up the balloon and click on the button labeled "Press to 
Collect $$$." Clicking this button will start you on the next 
balloon and will transfer the accumulated money from your 
temporary bank to your permanent bank labeled "Total Earned." 
It is up to you to decide how much to pump up each balloon.  A 
balloon could pop between 1 and 128 pumps and the average 
balloon will pop at 64 pumps. Thus, although there is no telling 
when any particular balloon will explode, your overall best 
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strategy is to pump 64 times one average for each balloon. If the 
balloon pops before you click on "Collect $$$," then you move 
on to the next balloon and any money in your temporary bank is 
lost. Exploded balloons do not affect the money accumulated in 
your permanent bank. In total there will be 20 balloons. Try to 
get as many points as possible. At the end of the session we will 
take the number of points you have earned on your attempt on 
this task and the attempt on the other task, and compare these 
point totals with those of the other participants in the experiment. 
The amount of money you will receive will depend on your 
performance on the task. You will not know if your score is high 
enough until you are finished, so do your best the whole time. 
Good Luck!!!  
Delay Discounting Procedure (DDP; Kirby & Marakovic, 1996). The DDP 
provides a measure of the degree to which an individual shows preference for either 
small, immediate rewards or larger, delayed rewards, which may be stated as the rate at 
which the subjective value of deferred rewards decreases as a function of the delay until 
they are received. Previous research has shown that individual's discount curves are well 
described by the following hyperbolic discount function (Mazur 1987): V= A / (1+kD) 
where V is the present value of the delayed reward A at delay D, and k is a free parameter 
that determines the discount rate. All delays below are measured in days, and the values 
of k are scaled accordingly. As k increases the person discounts the future more steeply. 
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Therefore, k can be thought of as an impulsiveness parameter, with higher values 
corresponding to higher levels of impulsiveness. 
 The k values provided by the Kirby questionnaire fall within 10 discrete 
categories: .00016, .00025, .00063, .0016, .0039, .010, .0126, .065, .16, and .25; based on 
the answers to the 27 items, participants were assigned one of these k values. The Kirby 
questionnaire provided k values for high ($85, $80, $75), medium ($60, $55, $50), and 
low ($35, $30, $25) value delayed rewards. This DDP in its various forms (including 
questionnaire and computerized versions) has been widely used in research on sensation-
seeking, impulsivity, and risk-taking, and has been found to correlate with other 
behavioral measures of impulsivity (Monterosso, Ehrman, Napier, O'Brien, & Childress, 
2001). Further, the questionnaire version of this task has been found to discriminate drug 
users and non-users (Kirby, Petry, & Bickel, 1999). 
At the start of the study, participants were shown a copy of the DDP and a verbal 
presentation of the instructions was given; a written version of the instructions also was 
provided at the top of the measure. The following script was read to participants:  
This questionnaire includes 27 choices below. In each case, please circle the 
reward you would prefer: the smaller reward today or the larger reward in a 
specified number of days. Although your choices should be based on your actual 
preference, they are not for real money.  
 
Design Considerations 
Outlined below are design considerations that shaped the conceptualization of the 
project, procedures, and data analytic strategy (the latter is described in detail below). 
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First, relapse following participation in residential substance abuse treatment was not 
assessed primarily to limit the scope of this dissertation project to changeability of affect- 
and personality-related variables as a function of treatment, with the goal of extending 
this approach to relapse in future work based on the observed findings in this study.   
Second, the impetus for dividing participants into 2 groups, with only one group 
having been assessed at pre-assessment was to be able to compare within and between-
groups and eliminate the possibility of pre-testing effects. With regard to the latter, a 
number of clinical and research studies have evidenced improvement on self-report 
measures simply based on repeated administration (Anastasi & Urbina, 1997; Kaufman, 
1990; Lazak, 1999). Indeed, such pre-testing effects provide the spurious appearance of 
improved function which makes the discernment of actual changes in variables of interest 
an arduous challenge for researchers. In an effort to diminish this problem, we assessed 
the first group at both pre- and post-treatment and the second only at post-treatment. 
Essentially, this design is the most robust test in order to have the ability to examine 
changes on affect- and personality-related variables as a function of treatment in absence 
of systematic pre-testing effects (Kazdin, 2005).  
Third, the decision for not ruling out certain individuals, but rather including all 
consecutive patients was made largely to increase the generalizability of our findings. 
Specifically, our study reflected the characteristics of those patients who typically present 
for substance abuse treatment, particularly inner-city residential treatment. The 
differences revealed between the groups provides information regarding the extent to 
which affect- and personality-related variables change over the course of 30 days of 
residential substance abuse treatment. Although follow-up data beyond one month would 
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be valuable in ascertaining the long-range stability of our findings, this study represents a 
first step of a larger research program. However, future work will be developed to 
examine specific community-based substance abuse treatment programs, treatment 
duration, and long-term follow-ups.  
Finally, the selection of the variables was a major point for the direction of the 
current study. Specifically, affect- related variables were selected because they have been 
long documented for their known link to engagement in substance abuse, their use as 
predictors of treatment outcome, and their malleability as a result of treatment. However, 
aside from research elucidating personality-related (i.e., disinhibition) variables and their 
relationship to substance use engagement, virtually no studies have examine these as 
predictors of treatment outcome, or how disinhibition changes as a function of treatment. 
In this way, affect-related variables served somewhat as a control variable, insofar as 
their frequently demonstrated ability to change as a function of treatment. However, 
because little is known about disinhibition in this regard we compared changes on both 
construct domains (affect and personality).  
 
Data Analysis 
Data analysis were focused on examining the extent to which scores on behavioral 
and self-report measures assessing affect- and personality-related constructs change 
across participation in 30 days of residential treatment: 
o Hypothesis 1: Examined the extent to which scores across each domain decreased 
from the pre-treatment assessment compared to the post-treatment assessment. 
Separate t-tests for the affect- and personality-related measures were used as the 
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primary test of significance. As recommended by Cohen and Cohen (1983), this 
approach allowed for between-group comparisons without reliance on change 
scores, which may have low reliability and may produce spurious relationships. 
Participants were assessed across the following domains: 
o Affect-related scores 
 Anxiety-related symptoms (anxiety sensitivity, experiential 
avoidance) 
 Depressive symptoms 
 Negative affect 
 Stress reactivity 
o Personality-related (disinhibition) scores 
 Risk-taking propensity 
 Impulsivity (delayed discounting) 
o Hypothesis 2: Examined the extent to which differences in hypothesis 1 persisted 
after controlling for group differences (pre-post vs. post-only group) at post-
treatment. This second hypothesis was used to evaluate the extent to which 
changes from pre-treatment to post-treatment for the pre-post group were due to 
the effects of repeated administration of measures. Thus, between-groups 






Chapter 4: Results 
Demographic Characteristics and Substance Use Patterns at Pre-Treatment for Group 1  
Descriptive statistics for the baseline demographics and the various classes of 
drugs endorsed by individuals in the pre-post group who received both assessments are 
provided in Table 1. Specifically, for participants in the pre-post group (n = 41), the mean 
age was 38.0 years (SD = 10.0; range = 18 - 57), 83.3% were male and 94.8% African 
American. The remaining racial/ethnic composition of the sample was as follows: 2.7% 
Caucasian, 1.2% Hispanic/Latino, and 1.2% reported other. With respect to the highest 
level of education, 13.6% reported finishing 8th grade or less, 29.2% reported finishing 
some high school, 37.5% reported completing a high school degree or GED, 10.4% 
reported having attended some college or technical school, 1.2% reported completing 
college degree, and 1.2% reported having attended graduate school or obtained a graduate 
or professional degree. Income was transformed into a dichotomous variable (0 = all 
income levels between $0 - 9,999; 1 = income level of $10,000 and over). Furthermore, 
in terms of marital status, participants were categorized as either single (72.9%) or not 
single. Of those who were not considered single, 6.9% were married, 5.2% married but 
separated, and 17.2% were living with a partner as if married. With regard to 
employment status, participants were categorized as employed (19.0%) or unemployed 
(81.7 %). Whether individuals were employed part-time (1.7%) or full-time (15.5%) did 
not influence the results. The most frequently endorsed substance used at any one time 
for Group 1 was alcohol (72.4%), followed by marijuana (70.8%), crack/cocaine 
(58.3%), PCP (47.9%), opiates and hallucinogens (25.8%), stimulants (14.6%), sedatives 
(16.7%), and inhalants (8.3%). With regard to weekly use prior to admission into the 
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treatment center, rates of use were reported as follows: alcohol, 20.8%; marijuana, 
20.8%, crack/cocaine, 37.5%; and opiates, 18.8%. 
 
Descriptive Statistics for Affect- and Personality Indicators at Pre- and Post- Treatment 
for the Pre-Post Group 
Means and standard deviations for all study variables at pre-treatment for the pre-
post group are presented in the first column of Table 2. As for disinhibition scores at pre-
treatment, mean and standard deviations for these measures were reported as follows: 
BART (M = 41.7, SD = 11.8), delay discounting (M = 37.3, SD = 7.8), and impulsiveness 
(M = 9.31, SD = 4.5). Furthermore, baseline scores of affective-related variables were 
reported as follows: experimental avoidance (M = 96.0, SD = 9.7), state anxiety (M = 
89.9, SD = 10.8), trait anxiety (M = 51.8, SD = 4.6), positive affect (M = 96.0, SD = 9.7), 
negative affect (M = 49.4, SD = 5.7), depressive symptomatology (M = 24.1, SD = 9.1), 
and stress reactivity (M = 36.1, SD = 12.2). In regard to disinhibition variables at post-
treatment, mean and standard deviations for these measures were reported as follows: 
BART (M = 32.8, SD = 13.6), delay discounting (M = 37.1, SD = 7.8), and impulsiveness 
(M = 8.8, SD = 4.2). Furthermore, post-treatment scores of affective-related variables 
were reported as follows: experimental avoidance (M = 96.1, SD = 9.0), state anxiety (M 
= 89.9, SD = 9.9)/trait anxiety (M = 52.7, SD = 3.7), positive (M = 50.7, SD = 
9.37)/negative affect (M = 30.9, SD = 5.3), depressive symptomatology (M = 17.2, SD = 
10.4), and stress reactivity (M = 30.2, SD = 11.2). Comparisons of these pre and post 




Relationships among Demographics, Self-Reported Affect- and Personality-Related 
Measures within the Pre-Post Group  
Correlations among Demographic Variables. The relationship among 
demographics variables for the pre-post group are presented in Table 3. Income level was 
related to employment status (r = .34, p < .01) and marital status (r = .24, p = .05), but 
was not related to age (r = -.13) or education level (r = .11). Age was related to marital 
status (r = -.33, p < .01) but no other demographic variables.  
Correlations among Affect-Related Variables. A number of the affect measures 
were significantly related to each other at pre-treatment for the pre-post group. 
Experiential avoidance was significantly related to depressive symptomatology (r = .59, 
p < .01), emotion regulation (r = .60, p < .01), and stress reactivity (r = .37, p < .05). 
Depressive symptomatology was significantly related to stress reactivity (r = .38, p < 
.05), and negative affect (r = .41, p < .01). Emotion regulation difficulties was 
significantly related to depressive symptomatology (r = .53, p < .01) and stress reactivity 
(r = .63, p < .01). Furthermore, affect scores at post-treatment also yielded significant 
relationships between variables. For example, experiential avoidance was significantly 
related to state anxiety (r = .29, p < .05). State anxiety scores at post-treatment were 
significantly related to positive affect (r = .58, p < .01), and stress reactivity (r = .34, p < 
.01). Depressive symptomatology was significantly related to emotion regulation 
difficulties (r = .69, p < .01) and stress reactivity (r = .56, p < .05).  
Correlations among Personality-Related Variables. There was no statistically 
significant relationship among the behavioral and self-report measures of disinhibition at 
pre-treatment. Specifically, self-reported impulsiveness was not correlated with either 
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delay discounting (r = .14, p = ns) or the BART (r = -.07, p = ns), and the BART was not 
correlated with delay discounting (r = .17, p = ns). Additionally, there were no post-
treatment relationships among the behavioral and self-reported personality measures, 
namely self-reported impulsiveness was not related to delay discounting (r = .11, p = ns) 
or the BART (r = .09, p = ns). As with pre-treatment, BART score did not correlate with 
delay discounting (r = -.13, p = ns). 
 
Results Specific to Aim 1: Within-Group Comparisons of Affect- and Personality 
Indicators at Pre- and Post- Treatment for the Pre-Post Group 
To examine the extent to which significant scores across affect and personality 
domains decreased from pre- to post-treatment specific to Aim 1, paired t-tests were 
used. Further, effect size statistics are reported to describe the magnitude of the 
significant change scores from pre- to post-treatment (Cohen & Cohen, 1983). Results 
indicated a significant decrease on BART score from pre (M = 41.7, SD = 11.8) to post-
treatment, [M = 32.8, SD = 13.6, t[34] = 3.55, p < .01, ηp2 = .30). However, no significant 
changes were found for delay discounting (t[34] = 0.70, p = ns) or impulsiveness (t[34] = 
0.80, p = ns). Further examining pre-post changes for group 1 on affective-related 
measures, significant differences were found for stress reactivity from pre (M = 36.1, SD 
= 12.2) to post-treatment, (M = 30.2, SD = 11.2, t[34] = 2.32, p = .05, η p2 = .16); and 
depressive symptoms from pre (M = 24.1, SD = 9.1) to post-treatment, (M = 17.2, SD = 
10.4, t[34] = 3.90, p < .01, η p2 = .34). For experiential avoidance (t[34] = -0.48, p = ns), 
state (t[34] = 0.40, p = ns) and trait anxiety (t(34) = -0.83, p = ns), positive (t[34] = -1.16, 
p = ns) and negative affect (t(34) = -0.30, p = ns), and emotion regulation difficulties 
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(t[34] = 0.40, p = ns), no significant differences were found. Findings suggest a general 
change (decrease) on BART scores, stress reactivity, and depression symptoms from pre- 
to post-treatment, which is consistent with Aim 1 (see Table 2). All variables were 
plotted to observe for non-linear relationships.  
 
Results Specific to Aim 2: Between-Group Comparisons of Sample Characteristics and 
Substance Use at Pre-Treatment 
A between-group comparison analysis was conducted to determine the extent to 
which sample characteristics and substance use between the pre-post group and post-only 
group were significantly different from each other at pre-treatment. Two significant 
differences emerged with respect to referral source and opioid use between groups. 
Specifically, individuals assigned to the post only group were more likely to have been 
court mandated, χ2(1) = 11.6, p < .001, than to have been referred by a different source, 
including private agency, self-referral, church, and other. Furthermore, opioid use 
differed between the pre-post group (25.8%) and the post-only group (42.4%), χ2(1) = 
5.62, p < .05. Comparisons also indicated that individuals assigned to the pre-post group 
and post-only group were not significantly different from each other demographic 
characteristics, including age (t[63] = 0.37, p = ns), gender [χ2(1) = 0.46, p = ns], marital 
status [χ2(1) = 0.77, p = ns], total household income [χ2(1) = 1.34, p = ns], employment 
status [χ2(1) = 0.79, p = ns], and education [χ2(3) = .53, p = .05]. For alcohol, marijuana, 
crack/cocaine, PCP, as well as the other drugs assessed, no significant differences were 
found. Please refer to Table 1 for additional information. When controlling for 
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differences with respect to referral source and opioid use between the pre-post group and 
post-only, the changes across variables in Aim 1 remained significant. 
Next, to address the influence of practice effects due to repeated administration of 
the measures, one-way between-groups analysis of variance (ANOVAs) were conducted 
to compare post-treatment scores between the pre-post group and post-only (see Table 4). 
There was a significant difference between the pre-post group (M = 37.1) and post-only 
(M = 41.2) on delay discounting scores at post-treatment, [F(1,49) = 7.55, p < .05, η p2 = 
.12], suggesting the possibility of practice effects for this measure. All other study 
variables did not indicate a significant difference at post treatment between groups. 
Specifically, no significant differences were found on BART scores between the pre-post 
group (M = 32.8, SD = 13.6) and post-only (M = 33.9, SD = 11.8), [F(1,48) =0.05, p = 
ns, η p2 = .01], depressive symptoms [F(1,49) = 0.03, p = ns, η = .01], and stress reactivity 
[F(1,49) = 1.07, p = ns, η = .03]. Therefore, in line with Aim 2, it is unlikely that any 
change in BART scores, depressive symptoms, and stress reactivity within the pre-post 
group could be attributed to the influence of pre-testing. Results of these analyses are 
summarized in Table 4 for between-group conditions.  
 
Chapter 5: Discussion 
Substance abuse treatment outcome studies have shown positive effects for a 
large number of drug users with regard to reduction in substance use, criminal activity, 
and improvement of general well-being (Wallace, 2001). Affect- (e.g., depressive and 
anxiety symptoms) and disinhibition–related variables (e.g., impulsivity, risk taking) are 
related to the development and maintenance of substance use, and these variables 
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distinguish between substance users with and without Axis I and II disorders that may 
interfere with treatment success, such as depression, anxiety disorders, or antisocial 
personality disorder (Guydish, 1999). Nevertheless, there is a dearth of research focused 
on understanding the extent to which these variables are affected by standard substance 
use treatments, and more specifically, the extent to which they may change throughout 
the course of substance use treatment. Towards this end, the current study examined the 
extent to which relevant affect- and personality-related variables change during the 
course of 30-day residential substance abuse treatment. Specifically, we examined the 
degree to which scores on affect (i.e., depression symptoms, anxiety, stress reactivity, and 
negative affect) and personality-related constructs (i.e., risk taking, impulsiveness, and 
delay discounting) would change during substance abuse treatment in a sample of 41 
adults. An additional sample of 40 adults was tested at 30 days to assess practice effects 
and to be used as a control where pre-post differences were found.  
Risk taking as indexed by participants’ BART scores significantly decreased from 
pre- to post-treatment. However, there was no significant pre-post change on other 
disinhibition variables of impulsiveness and delay discounting. Depressive symptoms 
significantly decreased from pre- to post-treatment. Results also indicated a significant 
decrease on pre-post scores of stress reactivity. Measures of experiential avoidance, state 
and trait anxiety, negative affect, and emotional regulation difficulties did not 
significantly change from pre- to post treatment. Moreover, data from the post-test only 
group suggests that the decrease across each measure was not simply due to the influence 




Influence of Standard Residential Substance Abuse Treatment on Affect and Personality 
Indicators 
It is important to disentangle possible reasons why study variables might have 
been influenced by participation in residential substance abuse treatment over the course 
of treatment. Because the current investigation occurred in the context of a community-
based treatment program it did not afford the opportunity to randomly assign participants 
to different treatment modalities nor include a control group. Therefore, it is difficult to 
discern precisely which components of standard treatment may have evoked change on 
our study variables. Several explanations are offered that elucidate potential reasons 
changes were observed for each variable.  
Risk Taking. First and foremost, before considering the possibilities to explain the 
pre-post changes on BART scores, it is worthwhile to rule-out the chance that pre-testing 
resulted in the observed reduction in BART scores. Specifically, research conducted by 
Lejuez and colleagues (2004, 2005) have found BART scores to increase rather than 
decrease over repeated administration of the task, which is indicative of changes being 
influenced by practice. Given that participant scores decreased from pre- to post-
treatment, and were virtually identical to scores of the post-only group, changes on 
BART scores are likely to be a result of treatment gains. It may very well suggest that the 
BART is a useful tool for assessing and capturing risk taking as a change mechanism 
during treatment among inner-city substance abusers. Pre-post changes may, in fact, 




Moreover, it is also possible that brain functions changed as a result of treatment. 
Or, it is also possible that less drug toxicity led to decreased BART scores from pre- to 
post-treatment (i.e., substance use influenced brain function and the removal of 
substances influenced BART scores). Researchers at the Yale University School of 
Medicine’s Division of Substance Abuse have begun to utilize magnetic resonance 
imaging (MRI) scans as a way to examine brain function and brain changes during the 
course of substance abuse treatment (with the BART task being used in the protocol; 
Carroll, Potenza, & Rounsaville, in press). Specifically, the prefrontal cortical area of the 
brain (responsible for risk taking behaviors and impulsivity) may be altered during the 
course of treatment. These types of investigations will aid in our understanding of the 
intersection between brain functions and changes on risk taking at the biological level. 
Such studies also will help to better understand exactly how treatment changes brain 
function and differentiate between treatment influenced changes versus changes due to 
the removal of drug use.  
Pre-post changes on the BART may have resulted from increased sustained 
attention on the task. Although participants are given a semi-random ordering of 
balloons, the task can be considered quite repetitive. Some may argue that patients were 
more risky at pre-treatment and as a result paid less attention to the task, and during the 
course of abstinence individuals gained improvement on sustained attention which may 
have accounted for some of the changes on BART scores. It is noteworthy that in one of 
the few studies exploring sustained attention, Gillen and colleagues (2001) found that 
over 25% of admission to an inpatient substance abuse treatment program could be 
classified as cognitively impaired on the basis of sustained attention.  
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Finally, risk taking might have been modulated through program structure and 
accountability in the program. For example, individuals in the treatment program must 
adhere to strict guidelines that prohibits the use of any drugs (the center requires 
complete abstinence from drugs and alcohol, and any use is grounds for dismissal). 
Therefore, patients are made aware of the potential immediate negative consequences of 
their behavior. In addition to maintaining decisional-balance, patients also may become 
less risky on the BART by virtue of having scheduled activities as well as a formal 
structure for each day. Specifically, patients in the treatment program are accustomed to 
participating in didactic lectures and sessions within a full day, seven days a week. 
Therefore, these findings may be a function of the change in the environment and 
structure which, in turn, decreased risky behavior due to the interruption in the 
association between substance use and the drug-using environment. Thus, by providing 
patients with an environment where one can focus exclusively on behavior change may 
have been reason alone for the reported decrease on BART scores.  
Depression Symptoms. The current data supporting the impact of substance abuse 
treatment on depressive symptoms is consistent with the extant literature. Specifically, 
Guydish et al., (1998) found post-treatment depressive symptoms to decrease by more 
than 50% after a 1 month course of substance abuse treatment and remained at this level 
throughout a 6 month follow-up period. Pre-post changes on depressive symptom scores 
might be attributed to the normal course of depression. Perhaps because depressive 
symptoms are thought to be cyclical with periods of waxing and waning may be reason 
enough to demonstrate change on depression symptoms. It might be that substance 
abusers become more self-aware of their depressed mood and rather than use drugs as a 
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means to deal with such disposition, they have learned healthy and adaptive ways to cope 
with depressive symptoms.  
Depressive symptoms may have decreased as a result of patients engaging in 
group activities, which can be thought of as a step in behavioral activation. That is, group 
activities: 1) increase positive reinforcement; 2) increase social support; and 3) decrease 
substance use involvement (cf., Lejuez, 2004). In one way, substance use increases 
isolation, which then serves to increase depressive symptoms. Alternatively, involvement 
in group activities decreases isolation, which may result in a decrease in depressive 
symptoms. Therefore, by making these changes it stands to reason that depressive 
symptom scores would decrease during the course of treatment.  
Finally, pre-post changes on depressive symptom scores may be due to the effects 
of the treatment, which incorporated a multimodal approach to substance abuse, 
including functional analysis, Alcoholics Anonymous (AA), Narcotics Anonymous (NA), 
and relapse prevention. Each specific component of these treatments might aid in 
reducing depression symptoms, including involvement in group meetings that encourage 
self-efficacy, participation in rewarding activities, and/or having the support of peers 
throughout the treatment process, which can be difficult to find for patients seeking to 
reduce substance use.   
Stress Reactivity. Germane to the current sample, African Americans, in 
comparison to other racial/ethnic groups, are at higher risk for developing physical 
conditions as a result of stress reactions (e.g., hypertension, stroke, and cardiovascular 
disease; Schneider et al., 2001). There is substantial evidence that stress reactions can be 
a result of ongoing life circumstances, including economic hardship, lack of control of 
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life circumstances, and social instability (Meyers, 2002). Thus, economically 
disadvantaged minorities are among the groups judged to be at greater risk for stress 
reactions (Healthy People 2000, p.215).  First, lack of employment, substance-filled 
neighborhoods, coupled with housing difficulties, may have contributed to the heightened 
stress reaction of these patients at baseline. Therefore, pre-post decreases on stress 
reactivity scores may be a function of simple removal from their largely impoverished 
environments. Recent data from divergent sources suggest that individuals with low 
income tend to be exposed to significant stressful events than other groups and are 
required to cope with stress reactions for longer periods of time (Chambless & Williams, 
1995; Meyers et al., 2002; Schneider et al., 2001). For this reason, changes may have 
been enhanced by especially elevated levels of stress reactivity at baseline. 
It is plausible that scores on stress reactivity decreased as a result of the 
components of residential treatment that focus on providing educational services (e.g., 
GED courses), employment skills (e.g., job training, placement interviews), and 
transitional housing arrangements throughout treatment. Patients may have demonstrated 
lower stress reactivity at the post-test on account of the fact that treatment addressed 
patients’ adverse life circumstances and provided them with tools to enhance their well-
being. Moreover, the stable, safe, and supportive nature of residential treatment may have 
facilitated change in the participants, given that many were homeless, earned less than 
$10,000 each year, or lived in neighborhoods pervasively affected by substance abuse. 
Residential programs potentially offer all of these benefits in one coherent package that 
removes individuals from their substance-abusing environment and provides them with a 
supportive place to achieve abstinence.  
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Given the high rates of co-morbidity between stress and depression in the current 
study as well as in the extant literature, it may be the case that as stress levels decreased, 
so did levels of depression (and vice versa). This sets the stage for future investigations, 
as researchers could examine interactions between variables that may fit within a larger 
model of change in treatment.  
 Treatments Components. Given that risk tasking, depression, and stress reactivity 
evidenced change as a function of participation in treatment, it is important to elucidate 
how the residential program influenced the study variables. The primary goal of the 
current residential treatment program is for substance abusers to master skills that will 
help to maintain abstinence from alcohol and other drugs. Several treatment approaches 
are utilized in this setting, including functional analysis, standard community-based 
treatment, and 12-step facilitation (NA/AA). Each of these treatments is described as well 
as their influence on significant change indicators. 
One critical component of the residential treatment program that may have 
influenced risk-taking, stress reactivity, and depression is the functional analysis. Patients 
are asked to identify thoughts, feelings, behaviors, consequences, and circumstances 
before and after the drug use. The functional analysis plays a critical role in helping 
patients assess the determinants, or high-risk situations, that are likely to lead to 
substance use which provides insight into some of the reasons why an individual may be 
using substances (e.g., to cope with interpersonal difficulties, to experiences risk or 
euphoria not otherwise available in the patient’s life). Additionally, patients are 
encouraged to unlearn old habits and learn or relearn healthier skills and habits. Strategies 
from the functional analysis are made as broad as possible. For example, skills are 
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applied to difficulty coping (e.g., social isolation, unemployment). Substance abusers in 
the program are taught these skills as both specific strategies (applicable in the here and 
now) and general strategies that can be applied to a variety of other problems.  
Furthermore, patients undergo standard community-based treatment that also may 
have led to a decrease on the study variables. Typical components of this treatment 
include (1) social and recreational counseling, (2) employment counseling, (3) drug 
refusal training, (4) anger management, and (5) relaxation training. Similar to the 
standard community-based treatment, 12-step facilitation (TSF) is grounded in the 
concept that drug and alcoholism is a disease that can be controlled but never cured. In 
AA and NA, substance abusers are asked to commit to the program. Participants also are 
actively encouraged maintain journals of their AA/NA attendance and participation. The 
major change agent in the disease-model approaches is involvement with the fellowship 
of AA/NA and working the 12 steps. That is, the way to cope with nearly all drug- and 
affect-related problems is by attending meetings or deepening involvement with 
fellowship activities.  
   
Variables Not Influenced by Standard Residential Substance Abuse Treatment  
Both risk taking and delay discounting have been conceptualized in the literature 
as related constructs of disinhibition (Aklin et al., 2005; Lejuez et al., 2004). However, 
the fact that BART score evidenced a pre-post change during treatment and not delay 
discounting is somewhat surprising. Admittedly, little available data bears upon an 
explanation as to why risk taking shared little to no relation with delay discounting, 
though several arguments could be made. A possible reason for this lack of change may 
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be due to other nonspecific factors that often figure prominently in substance abuse 
(Stewart, 1999). Such relevant factors include, but are not limited to, functional 
impairments related to certain disorders (e.g., Axis I and II disorders and other co-
occurring conditions) or one’s perception of control and/or one’s ability to employ self-
regulative skills. Perhaps the lack of a strong association between BART score and delay 
discounting as well as the lack of change for the latter may be a result of different 
methodology (i.e., paper and pencil vs. actual behavioral assessment) and not that these 
variables measure different constructs. Available studies indicate that participants’ 
responses on paper and pencil tasks and observable behavior are often discrepant (e.g., 
Mitchell, 1999). Conceivably, both tasks differ markedly from each other in the ways in 
which risk taking is captured. For delay discounting, individuals are given a choice 
between a smaller immediate reward (i.e., risky choice) over a larger delayed reward 
(non-risky choice). For example, participants were asked to select from one of two 
choices; specifically, would you rather have $69 today or $85 in 91 days? Thus, riskiness 
is conceptualized as “bad” and the participant must learn this association and behave 
accordingly.  
In contrast, risk taking on the BART is conceptualized on a continuum in which 
riskiness is problematic only after a certain point, with that point varying on a case by 
case basis. Specifically, participants are told to inflate a computerized balloon that would 
pop between 1 and 128 pumps and the overall best strategy is to pump 64 times on 
average for each balloon. Thus, the probability that the balloon exploded on the first 
pump was 1/128. If the balloon did not explode after the first pump, the probability that 
the balloon exploded was then 1/127 on the second pump, 1/126 on the third pump and so 
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on up until the 128th pump at which the probability of an explosion will be 1/1 (i.e., 
100%). In either case, one plausible argument supporting the lack of relation between 
these tasks is based on the idea that each measure may tap dissociable aspects of risk 
taking which may not be as likely to change.  
Also contrary to expectation, several affect-related measures showed no 
significant pre-post change. Specifically, no significant differences were identified 
among anxiety (both state and trait level) and experiential avoidance scores, nor was 
there support for the hypothesis that patients with increased baseline levels of negative 
affect would report a decrease in their negative affect at post treatment. These 
nonsignificant findings are somewhat surprising given that highly anxious substance 
abusers have a tendency to report psychiatric symptoms associated with negative 
emotional responding (e.g., depression; Lillienfeld, 2001; Taylor, Koch, Woody, & 
McLean, 2006). As one example, it is generally recognized in the literature that substance 
abusers have a poor tolerance for anxiety states and negative affect that results from their 
ongoing substance use patterns and cycles of withdrawal (e.g., Litt et al., 2000). 
Consequently, the absence of change from pre- to post-treatment on anxiety scores may 
be driven by patients who attenuate these symptoms largely because of fear of their own 
responses to anxiety, which negatively reinforces substance use and thus makes it more 
difficult to change compared to other indicators. Therefore, scores on anxiety are seen 
following targeted relearning of maladaptive behaviors and are less amenable to change 
as a result of non-specific factors during treatment. For example, there are specific 
treatments for different anxiety disorders (OCD, Social Phobia, Generalized Anxiety, and 
PTSD), and simply sharing thoughts and feelings in a group setting may not translate into 
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changes on anxiety scores. In comparing baseline levels of state and trait anxiety to other 
samples, mean anxiety scores for the present sample were over two standard deviations 
above those for non-clinical men, and over one standard deviation for clinically anxious 
patients, including patients diagnosed with PTSD and panic disorder (Peterson & Reiss, 
2002). 
With regard to experiential avoidance, substance abuse provides a convenient and 
rapid means to mitigate, or otherwise avoid, unpleasant negative affect, including 
physical symptoms and negative thoughts. Therefore, it may be the case that the absence 
of change was due, in part, to the fact that experiential avoidance represents a learned and 
entrenched way of dealing with emotions. In order to observe change, longer-term 
interventions targeting experiential avoidance may be needed. Together, this lack of 
change across experiential avoidance and state and trait anxiety scores might stem from 
the fact that African American male substance abusers within urban environments may 
have an overall higher level of avoidance and anxious disposition, which make it difficult 
to produce any statistically significant change. As for emotion regulation, participant’s 
scores at baseline were in the non-clinical range which may be indicative of lower 
general emotion regulatory skills (see Gratz & Roemer, 2004). 
 
Limitations 
Before discussing the strengths and potential implications of these findings, it is 
important to acknowledge the limitations of such a preliminary study. First, the main 
shortcoming of this study is the relatively small number of subjects in the two groups. 
This small number of subjects limits the conclusions that can be drawn from 
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nonsignificant results, due to the possibility of type II error. In addition, the present 
sample is limited in the sense that it is comprised of a group of substance abusers who 
participated in the study for monetary reward. To rule out the possibility that the present 
results are related to a self-selection bias, it will be important for researchers to utilize 
recruitment strategies other than those related to monetary reward.  
Conclusions that can be drawn also are limited by our reliance primarily on self-
report measures. Several drawbacks with relying on self-report measures are especially 
pronounced in this sample (e.g., Campbell & Stanley, 1963; Ladouceur et al., 2000). 
Specifically, both the effects of chronic substance use and the low level of education 
among the sample suggests a potential lack of insight or cognitive ability to understand 
questions or provide an accurate report of behavior which might have influenced 
participants’ responses. Despite these potential barriers, the self report measures 
demonstrated moderate to high internal consistencies and also were correlated with each 
other, suggesting that the self report constructs may have been assessed reliably. 
Likewise, it is unclear as to whether many of the self-report measures are culturally 
sensitive and appropriately applied to the thoughts, feelings, and behaviors of inner city 
African Americans (Lowe, 2006). Behavioral measures, on the other hand, compliment 
self-report measures and address these limitations in that they rely less on subjective 
responses and more on actual behavior (i.e., multi-trait, multi-method framework; Griffin 
et al., 2003). Perhaps because behavioral tasks simulate situations under which real-world 
risk behaviors may occur (e.g., Bickel, Odum, & Madden, 1999; Crean, de Wit, & 
Richards, 2000; Mitchell, 1999; Vuchinich & Simpson, 1998). Furthermore, behavioral 
assessments emphasize observable behavior with choices and consequences akin to the 
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“real-world.” Future studies would benefit from multiple behavioral and self-report 
measures for each construct. 
One major limitation of the current findings is the broader concept of not having 
included a comparison group. Therefore, we cannot differentiate the extent to which 
individuals might have improved or changed without treatment. The question could be 
answered by including a no-treatment control group in the future experimental design. As 
a way to improve the current methodological design which included a pre-post and post 
only group, the next step would be to include a no-treatment design that would directly 
control for threats to internal validity. A no-treatment control also will help to better 
explain why individuals might have changed on the study variables.  
Participants were not assessed at follow-up, which makes it difficult to 
demonstrate the extent to which change in subjects across treatment is linked to treatment 
success or other aspects of substance abuse. For example, it is unclear as to whether 
changes in treatment persist following treatment. The issues raised can only truly be 
addressed through scientifically rigorous experimental procedures that include a follow-
up component. Although follow-up data beyond one month would be valuable in 
ascertaining the long-range stability of our findings, this study represents a first step of a 
larger research program. Thus, future research would likely yield information about the 
mechanisms of action from which clinical researchers can derive the most efficacious and 
effective treatments on a patient-to-patient basis.  
Another limitation involves the fact that the current study included a 
homogeneous sample of inner-city, male, African American substance abusers. 
Accordingly, there needs to be some caution before making generalizations to other 
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samples. Researchers often consider inner-city substance abusers together, but as pointed 
out by Kelder et al. (2003), important ethnic/racial differences exists in prevalence rates, 
and more importantly, substance use disproportionately impacts African Americans who 
incur increased relative risk of mortality from diseases associated with substance use, 
including HIV infection (USDHHS, 2003). While not necessarily generalizable to all 
samples of inner-city substance abusers, the current study provides valuable data on a 
group whose affect and personality characteristics might allow for the development of 
unique treatment opportunities. Future studies should expand these methods to more 
diverse samples to examine the scope and generalizability of these change mechanisms of 
treatment among other substance abusing groups. These findings, if truly robust, should 
hold across samples and study populations, particularly in residential treatment settings 
where risk taking, depressive symptoms and increased levels of stress are often the rule, 
not the exception. Taken as a whole, this study is limited by its preliminary nature.  
 
Strengths of the Current Study and Future Directions 
Despite the above limitations, there are several strengths of the current study as 
well as future directions in this line of research. The current methodological design made 
it possible to examine pre-post changes while controlling for practice effects, which is a 
major asset of this study.  In this way, we obtained more stringent estimates of the 
magnitude of change across affect- and personality-related variables than would analyses 
without these statistical controls. As expected, the present data support the hypothesis 
that changes on affect and personality measures over the course of treatment were not due 
to the influence of pre-testing. Specifically, BART scores were not significantly different 
 
58 
between Group 1 and Group 2 at post-treatment. As found with affect-related variables, 
post-treatment scores on depression and stress reactivity across both groups were 
virtually identical and thus were not influenced by practice effects. Naturally, these data 
will need to be extended to processes in the context of a follow-up design where 
predictors can be used to examine changes throughout treatment and the extent to which 
these changes persist. As with all research that utilizes repeated assessments, it is 
important to acknowledge the possibility of practice effects. Even though practice effects 
did not influence the findings, a future study will benefit from utilizing a complete 
Solomon’s four-group design to more thoroughly control for the effects of pre-testing 
(i.e., pretest sensitization; Kazdin, 2003). Essentially, to fully address this potential 
methodological issue, a minimum of four groups is required. These four groups in the 
design are the two groups, where one group receives treatment and the other does not, 
plus another two groups of post-test only. To illustrate the design, the sequence of events 
in the design (e.g., treatment, control) for each group will be presented symbolically 
using the following notation: R stands for random assignment of subjects to conditions; 
Pr for pre-treatment assessment; Tx for the treatment; and Po for post-treatment 
assessment. The Solomon four-group design can be diagrammed as follows: 
  R Pr Tx Po 
  R Pr  Po 
  R  Tx Po 
  R   Po 
The current study also has the potential to build on the effectiveness of already 
existing residential programs. However, in order for this to be possible, future studies 
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need to replicate and extend these findings. For example, it would be necessary to 
investigate whether one specific model is better than another within residential settings 
(Cognitive Behavioral Therapy vs. 12-step or relapse prevention). Essentially, would 
these various treatment models have more or less change on risk taking, depressive 
symptomatology, and stress reactivity? Along these same lines, another area of 
development would be to explore the extent to which changes on these indicators persist 
across each treatment modality. Each respective question provides the opportunity to 
develop research that expands beyond the current study.   
The mechanisms responsible for changes on BART score, depressive 
symptomatology, and stress reactivity remain unclear. Therefore, future studies must test 
theories that might explain changes on these variables during residential treatment. 
Bandura’s social-cognitive model appears to provide a theoretical framework that is 
consistent with this line of research. For example, this model posits how change of 
behaviors depends on an interaction among one’s environment and one’s personal 
characteristics. Specifically, the facilitation of change is centered on having the 
behavioral means, resources, and social support under which individuals develop a sense 
of control or perceived self-efficacy. Thus, in guiding one’s behavior, self-regulative 
skills, including affective reactions to one's own conduct are important constructs to 
consider. Such skills will determine the potential situations in which an individual may 
find the necessary skills to resist social pressures and engagement in substance use that 





Treatment Modification and Development Implications 
With respect to the clinical relevance and the extent to which these findings may 
be generalizable, it is important to understand the extent to which changes occur in more 
standard substance use treatments and why specifically this treatment. This is one of the 
first empirical investigations to examine the changeability of disinhibition in general, but 
more specifically exploring changes on affect variables as well with an underserved 
population. It is conceptually useful to know that theoretically-relevant personality 
variables are susceptible to change for the purpose of improving existing treatment and 
enhancing substance abuse programs. Although these data cannot be directly translated 
into a treatment per se, it does provide paths for future research which seeks to isolate 
specific treatment components of existing interventions that differentially reduces risk 
taking, depressive symptomatology, and stress reactivity for inner-city substance abusers. 
Therefore, these data set the stage for studies to not only describe changes in treatment, 
but also to highlight the mechanisms responsible for these changes and differentiate 
which indicators might be expected to change on their own with abstinence (occurring 
naturally vs. through formal treatment), and/or by removal from a drug-involved, 
impoverished, or criminal environment. Essentially, the logical step is to explore whether 
changes are due to the type of treatment or simply abstinence.  
 
Conclusions and Recommendations 
This study is the first in a promising line of research demonstrating that standard 
residential treatment can impact variables that are known contributors to substance use 
(i.e., risk taking propensity, depression symptoms, and stress reactivity). More 
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compellingly, our results remained significant even after controlling for the potential bias 
of repeated administration of the measures. Each of the domains that demonstrated a 
decrease as a result of treatment taps theoretically and practically relevant predispositions 
that may offer additional information related to substance abuse treatment. Furthermore, 
such information could potentially lead to enhanced discrimination of effective treatment 
strategies across various levels of substance abuse severity by identifying salient 
variables for intervention.  
Given the ability for risk taking and affect-related variables to change, larger scale 
investigations need to elucidate the mediating and moderating emotion- and disinhibition-
based variables which might influence levels of change. For example, future research is 
necessary to determine which variables moderate the relation between stress reactivity 
and depression scores across pre-post change. Investigations of this nature could 
potentially uncover self-regulatory mechanisms and coping skills that replace decisions to 
self-medicate, leading ultimately to pathway models of substance abuse that may offer 
researchers and clinicians credible information to guide their interventions. Furthermore, 
these findings highlight the importance of the use of behavioral tasks to allow researchers 
to collect more precise, time- and context-specific results. In an effort to inform treatment 
modification and enhancement, depending on the level of change across these variables, 
individuals could be targeted to receive treatment modules developed to address these 
specific behaviors. Thus, a future step of this study would be to assess how changes 
across these variables predict treatment completion and long-term abstinence. A related 
question is whether changes on disinhibition variables are sustained after treatment 
completion. What are the key variables responsible for producing change on targeted 
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affect and personality related variables? Treatment development studies should aim to 
supplement treatment modules that include both personality and environmental factors. 
These findings, along with related studies, may eventually provide the theoretical 
framework for treatment studies that can target these factors and explore the 
development, treatment and prevention of substance abuse disorders. This study was an 
important first step in this process, as it contributed to our understanding of the 






























Table 1. Means, standard deviations, and baseline comparisons of pre-post and 
post only, as well as percentages of individuals acknowledging any use, weekly 
















t(63) = 0.37, p = ns 
 






χ2(1) = 0.46, p = ns 
 






χ2(1) = 1.34, p = ns 
 
















χ2(1) = 0.77, p = ns 
 







χ2(1) = 0.79, p = ns 
 
Education Level 
   
χ2(3) = .53, p = .05 
 






     






      

















   
 






χ2(1) = 11.6,  
p = .001 
 
Acknowledging Any Use 
   
    
     Alcohol 
72.4% 81.8%  
      
     Marijuana 
70.8% 75.8%  
      
     Stimulants (other than 
cocaine) 
14.6% 12.1%  
      
     Crack/Cocaine 
58.3% 63.6%  
      
     Opiates 
25.8% 42.4%  
      
     Hallucinogens (other 




















 Pre-post (n=41)a 
M (SD) 
Post only (n=40)b 
M (SD) 
Statistic (a/b) 
PCP  47.9% 57.6%  
      
     Sedatives 
16.7% 24.2%  
      
     Inhalants 
08.3% 18.2%  
      
     Polysubstance Use 





   
      
     Alcohol 
20.8% 27.1%  
      
     Marijuana 
20.8% 35.4%  
      
     Stimulants (other than 
cocaine) 
08.3% 47.9%  
      
     Crack/Cocaine 
37.5% 39.4%  
      
     Opiates 
18.8% 06.3%  
      
     Hallucinogens (other 
than PCP) 
04.2% 16.7%  
      
     PCP 
08.3% 06.3%  
      
     Sedatives 
04.2% 14.6%  
      
     Inhalants 
02.1% 04.2%  
      
     Polysubstance Use 
26.7% 35.4%  
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Table 2. Change in relationships across variables from pre-post treatment. 
 
 Pre [M(SD)] Post [M(SD)] Statistic, p value 
1. Experiential Avoidance 96.0 (9.7) 96.1 (9.0) t(34) = -0.48, p = ns 
2. State Anxiety 89.9 (10.8) 89.9 (9.9) t(34) = 0.40, p = ns 
3. Trait Anxiety 51.8 (4.6) 52.7 (3.7) t(34) = -0.83, p = ns 
4. Depressive 
Symptomatology 
24.1 (9.1) 17.2 (10.4) t(34) = 3.90, p < .01 
5. Positive Affect 49.4 (9.6) 50.7 (9.3) t(34) = -1.16, p = ns 
6. Negative Affect 30.1 (5.7) 30.9 (5.3) t(34) = -0.30, p = ns 
7. Delay Discounting 37.3 (7.8) 37.1 (7.8) t(34) = 0.70, p = ns 
8. Stress Reactivity 36.1 (12.2) 30.2 (11.2) t(34) = 2.32, p = 05 
9. Emotion Regulation 77.6 (22.3) 75.1 (24.1) t(34) = 0.40, p = ns 
10. Impulsiveness 09.3 (4.5) 08.8 (4.2) t(34) = 0.80, p = ns 
11. BART 41.7 (11.8) 32.8 (13.6) t(34) = 3.55, p < .01 


































Table 3. Internal consistencies (α) and intercorrelations among baseline demographics, 
behavioral and self-reported affect and personality measures at pre- and post-treatment.        
    
      Note:  BART indicates the average number of pumps on balloon task, excluding balloons 










α 1 2 3 4 5 6 7 8 9 10 
Self-report measures  Pre 
  Post 
Pre 
  Post 
Pre 
  Post 
Pre 
    Post 
Pre 
    Post 
Pre  
  Post 
Pre 
    Post 
Pre 
    Post 
Pre 
    Post 
Pre 
    Post 
1. Experiential Avoidance .74 -- -.02  
      





       
    -.10 
.06 
      




.37*     
       
      .01 
.60**    
     
    -.06 
.48** 
     
    -.17   
-.22   
 
     .06 
2. State Anxiety  .69  -- -.09 
 
-.12 
-.13    
 
   .23 
.46**   
 




.31    
 
    .34* 
.10 
       
     .23 
.15     
 
    .12 
.11  
 
     .09 




















   .24 
4.Depressive 
Symptomatology 
.76    -- .01    
 




.38*    
 
  .56** 
.53**  
 
  .69** 
.42**   
 
  .43** 
.10  
 
     .06 




   
     .20 
-.23  
 
    .01 
.09  
 
    .07 
.01  
 
     .02 











     .28 
7. Stress Reactivity .89       -- .63**   
 
  .68** 
.38*  
 
    .33* 
-.13  
 
     .12 
8. Emotion Regulation .80        -- .69**. 
 
  .54** 
-.35*  
 
     .14 
9. Impulsiveness .72         -- -.07  
 
     .09 
Behavioral tasks            
10. BART --          -- 
11. Delay Discounting 
 
.94           
Demographics            
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Table 4. Change scores on affect and personality-related variables at post-treatment 













Experiential Avoidance 96.1 (9.1) 93.4 (9.8) F(1,49) = 0.88, p = ns 
State Anxiety 89.9 (9.9) 92.6 (17.3) F(1,49) = 1.07, p = ns 
Trait Anxiety 52.7 (3.7) 49.7 (8.3) F(1,49) = 0.62, p = ns 
Depressive Symptomatology 17.2 (10.4) 17.3 (11.4) F(1,49) = 0.03, p = ns 
Positive Affect 50.7 (9.4) 51.9 (5.5) F(1,49) = 0.01, p = ns 
Negative Affect 30.9 (5.3) 29.3 (8.1) F(1,49) = 1.05, p = ns 
Delay Discounting 37.1 (7.8) 41.3 (6.3) F(1,49) = 7.55, p < .05 
Stress Reactivity 30.2 (11.2) 32.7 (8.5) F(1,49) = 1.07, p = ns 
Emotion Regulation 75.1 (24.1) 75.8 (26.5) F(1,49) = 1.77, p = ns 
Impulsiveness 8.8 (4.3) 8.7 (6.1) F(1,49) = 0.35, p = ns 























Appendix A: Substance Abuse Treatment Settings 
 
Almost without exception, private and government funded methadone 
maintenance, outpatient, and residential substance abuse treatment programs are frontline 
approaches to promote recovery from substance abuse. Methadone maintenance 
treatments provide a form of medium-term, abstinence-oriented substitution treatment. A 
basic feature of methadone treatment is that the drug is prescribed on a constant-dose in 
order to stabilize the patient’s functioning while at this same time decrease their urges to 
use heroin. Whereas outpatient treatment programs usually consist of one to two evenings 
a week of group treatment. Partial hospitalization and day treatment programs are a form 
of outpatient treatment that require patients to reside in a treatment facility during the 
day, participating in the daily treatment regiment and then return home for the evening 
and overnight. Finally, before admission into residential treatment patients generally 
participate in a detoxification program lasting from 7 to 21 days. Following this initial 
phase, patients attend structured daily activities designed to facilitate recovery, usually 











Appendix B: Residential Treatment Approaches 
The mainstay of residential treatment incorporates a multimodal approach to 
substance abuse, including 12-step and/or relapse prevention. The 12-step model is 
evident in such programs as Alcoholics Anonymous, as well as peer support and 
governance (i.e., Narcotics Anonymous), all of which are directed towards recovery 
through abstinence. The overarching theme of this model is that addiction is a disease 
which is based on an underlying physical dependency and physiological predisposition, 
and the patient does not have control over his or her own behavior. This approach also 
emphasizes the role of spirituality in the recovery process. The effectiveness of substance 
abuse programs utilizing 12-step programs has been criticized for lacking sound 
methodologies (Ouimette, Finney, & Moos, 1997; Tonigan et al., 1996).  
Another common approach utilized in substance abuse treatment programs is 
relapse prevention (Marlatt & Gordon, 1985). This self-management approach is based 
on social learning theory (Bandura, 1977), and combines behavioral skills training, 
cognitive interventions, and overall lifestyle change procedures. The tenets involved in 
this treatment are referred to as cognitive behavior therapy (CBT). Specifically, the goal 
is to teach patients who are attempting to change over learned behavioral patterns how to 
anticipate and cope with relapse as well as challenge maladaptive thoughts and feelings 
that may interfere with this behavioral change. A major component of the relapse 
prevention model is the identification of high-risk situations (i.e., triggers) through self-
monitoring, self-efficacy ratings, and detailed analysis of past relapse episodes (Wilson, 
1992). Thus, the aim is to elucidate the factors that might lead to relapse and to increase 
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the patient’s awareness of the operation of these factors (Messina, Wish, & Nemes, 
2000). 
The empirical support for relapse prevention in substance abuse treatment has 
been generally encouraging. In a study comparing relapse prevention to interpersonal 
treatment in a residential setting, Ito, Donovan, and Hall (1988) found no between-
treatment differences on substance use, but did uncover differential effects on other post 
treatment measures including self-efficacy, impulsivity, and behavioral coping. In a 
similar study that comprised individuals with substance use dependency participating in 
behavior therapy, individuals receiving additional relapse prevention used significantly 
less substances in general, followed regime more reliably (i.e., taking disulfiram 
[Antabuse] on time), and reported better social relationships than individuals without the 
additional treatment (O’Farrell et al., 1998). Furthermore, a number of recent studies 
have investigated the efficacy of relapse prevention for cocaine-dependent individuals. In 
a study that randomly assigned cocaine-dependent patients to different treatment, McKay 
and colleagues (1997) compared relapse prevention to treatment as usual. Treatment as 
usual produced greater abstinence than individualized relapse prevention, while relapse 
prevention more effectively reduced cocaine use in those who had difficulty in achieving 
abstinence during and after treatment. In a study of delivery modality (i.e., individual vs. 
group therapy), Graham et al., (1996) found that the way in which relapse prevention was 
provided had no effect on drug and alcohol outcomes.  
Brown, Seraganian, Tremblay, and Annis (2002) evaluated matching substance 
use patient attributes to varying treatments. A total of 154 patients were randomized into 
two experimental groups. Seventy-two patients were randomly assigned to the 12-step 
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group and 61 patients were assigned to the relapse prevention group; 21 patients refused 
randomization and thus, were not included in the final analyses. The 12-step program 
consisted of 10 sessions and focused on the disease concept to achieving sobriety. 
Sessions were structured following a standard protocol each week, which including 
symptom review, discussion of program involvement, introduction and review of each 
session. This module was compared to a relapse prevention program (Marlatt, 1985) that 
involved 10 weekly sessions. During the initial counseling phase, an individualized 
treatment plan was developed for each patient, which identified the specific triggers, 
patterns of substance use, and consequences. All patients were matched on the following 
variables: age, gender, substance abuse profile, and psychological status. At the 6-month 
follow-up, four significant findings emerged. First, females with a multiple substance 
abuse profile reported better substance use outcomes with 12-step than their relapse 
prevention counterparts. Additionally, relapse prevention was found to maintain 
abstinence significantly longer for patients reporting low distress compared to patients 
with high distress. Of note, better outcomes were obtained when random assignment to 
treatment was consistent with the patient’s preference. The authors suggest that the 12-
step approach may provide the most favorable substance use outcomes for most groups of 
substance users. However, they also indicate that relapse prevention may be most suitable 







Appendix C: Weekly Therapy Schedule for Salvation Army Patients  














































































Appendix D: Demographic Information 
 
Age:   ____ 
Gender:     Female:  ____ (0)      Male:  ____ (1) 
 
Marital/Relationship Status:   
____ (1) Single (never married, living alone, divorced, widowed, etc)  
____ (2) Living with a partner as if married   
____ (3) Married but separated 
____ (4) Married 
 
Ethnicity/Race:      
____ (1) Black/African American ____ (4) Asian        
____ (2) White/Caucasian       ____ (5) Native American       
____ (3) Hispanic/Latino      ____ (6) Other: ____________  
 
Total Family/Household Income: please check one 
____ $0 – 9,999  ____ $40,000 - $49,999  ____ $80,000 - 
$89,999 
____ $10,000 – 19,999 ____ $50,000 - $59,999  ____ $90,000 - 
$99,999 
____ $20,000 – 29,999 ____ $60,000 - $69,999  ____ $100,000 or 
more 
____ $30,000 – 39,999 ____ $70,000 - $79,999   
 
Employment Status: 
____ (1) Unemployed      
____ (2) Employed part-time (working 1 – 30 hours a week)   
____ (3) Employed full-time (working more than 30 hours a week)      
____ (4) Home maker 
Occupation: ____________  
 
What is your referral source? ________________ 
 
Before entering the Salvation Army Harbor Lights Residential Center, what was 
your primary drug of choice? ________________ 
 
Have you ever been diagnosed with a psychiatric disorder? ‘Yes’ or ‘No’ 
If yes, which one(s): ________________  
  
Are you currently taking any medications? ‘Yes’ or ‘No’ 






Appendix E: AAQ 
 
Below you will find a list of statements.  Please rate the truth of each statement as it 
applies to you.  Use the following scale to make your choice.   
 
   1-----------2---------------3---------4--------------5--------------6---------------7     
Never   very seldom   seldom  sometimes   frequently   almost always   always              
true       true   true        true              true               true         true 
 
_______1.      I am able to take action on a problem even if I don’t know the right thing to 
do.  
 
_______2.  When I feel depressed or anxious, I am unable to take care of my 
responsibilities.  
 
_______3.  I try to stop thoughts and feelings that I don’t like by just not thinking 
about them.  
 
_______4.  It’s OK to feel depressed or anxious.  
 
_______5.  I rarely worry about getting my anxieties, worries, and feelings under 
control.  
 
_______6.  In order for me to do something important, I must have all my doubts 
worked out.  
 
_______7.  I’m not afraid of my feelings.  
 
_______8.   I try hard to avoid feeling depressed or anxious.  
 
_______9.   Anxiety is bad.  
 
_______10.   Despite doubts, I feel as though I can set a course in my life and then stick 
to it.  
 
_______11.   If I could magically remove all the painful experiences I’ve had in my life, 
I would do so.  
 
_______12.   I am in control of my life.  
 
_______13.   If I get bored of a task, I can still complete it.  
 
_______14.   Worries can get in the way of my success.  
 




_______16.   If I promised to do something, I’ll do it, even if I later don’t feel like it.  
 
_______17.   I often catch myself daydreaming about things I’ve done and what I would 

































Appendix E: AAQ 
    
     1-----------2---------------3---------4--------------5--------------6---------------7     
Never   very seldom   seldom  sometimes   frequently   almost always   always              
true       true   true        true              true               true         true 
 
 
_______18.   When I evaluate something negatively, I usually recognize that this is just 
a reaction, not a solid fact.  
 
_______19.   When I compare myself to other people, it seems that most of them are 
handling their lives better than I do.  
 
_______ 20.   It’s not necessary for me to learn to control my feelings in order to handle 
my life well.  
 
_______ 21.   A person who is really “together” should not struggle with things the way 
I do  
 
_______ 22.   There are not many activities that I stop doing when I am feeling 



























Appendix F: STAI - S 
A number of statements which people have used to describe themselves are given below. 
Read each statement and then circle the appropriate number to the right of the statement 
to indicate how you feel right now, that is, at this moment. There are no right or wrong 
answers. Do not spend too much time on any one statement but give the answer which 
seems to describe your present feelings best. 
 
 NOT AT ALL SOMEWHAT MODERATELY SO VERY MUCH SO 
1. I feel calm 1 2 3 4 
2. I feel secure 1 2 3 4 
3. I am tense 1 2 3 4 
4. I feel strained 1 2 3 4 
5. I feel at ease 1 2 3 4 
6. I feel upset 1 2 3 4 




1 2 3 4 
8. I feel satisfied 1 2 3 4 
9. I feel 
frightened 
1 2 3 4 
10. I feel 
comfortable 
1 2 3 4 
11. I feel self-
confident 
1 2 3 4 
12. I feel nervous 1 2 3 4 
13. I am jittery 1 2 3 4 
14. I feel 
indecisive 
1 2 3 4 
15. I am relaxed 1 2 3 4 
16. I feel content 1 2 3 4 
17. I am worried 1 2 3 4 
18. I feel 
confused 
1 2 3 4 
19. I feel steady 1 2 3 4 
20. I feel 
pleasant 
1 2 3 4 














Appendix F (continued): STAI – T 
A number of statements which people have used to describe themselves are given below. 
Read each statement and then circle the appropriate number to the right of the statement 
to indicate how you generally feel.  
   
   ALMOST 
NEVER 
SOMETIMES OFTEN ALMOST ALWAYS
21. I feel pleasant 1 2 3 4 
22. I feel nervous and restless 1 2 3 4 
23. I feel satisfied with myself 1 2 3 4 
24. I wish I could be as happy as others 
seem to be 
1 2 3 4 
25. I feel like a failure 1 2 3 4 
26. I feel rested 1 2 3 4 
27. I am “calm, cool and collected” 1 2 3 4 
28. I feel that difficulties are piling up 
so that I cannot overcome them 
1 2 3 4 
29. I worry too much over something 
that doesn’t really matter 
1 2 3 4 
30. I am happy 1 2 3 4 
31. I have disturbing thoughts 1 2 3 4 
32. I lack self-confidence 1 2 3 4 
33. I feel secure 1 2 3 4 
34. I make decisions easily 1 2 3 4 
35. I feel inadequate 1 2 3 4 
36. I am content 1 2 3 4 
37. some unimportant thought runs 
through my mind and bothers me 
1 2 3 4 
38. I take disappointments so keenly 
that I can’t put them out of my mind 
1 2 3 4 
39. I am a steady person 1 2 3 4 
40. I get in a state of tension or turmoil 
as I think over my recent concerns and 
interests 



















Appendix G: CES-D  
 
Below are questions about how you have felt in the PAST WEEK. For each question, 
please answer how often you have felt this way in the PAST WEEK.  
 
For each question: 
0 = Rarely or none of the time (less than one day) 
1 = Some ore little of the time (1-2 days) 
2 = Occasionally or a moderate amount of time (3-4 days) 
3 = Most of the time (5-7 days) 
 




















or a moderate 





































I felt that I could not shake off the blues even 
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or a moderate 






















































































































































Appendix H: PANAS 
 
This scale consists of a number of words that describe different feelings and emotions. 
Read each item and mark the appropriate answer in the space next to that word. Indicate 
to what extent you FEEL THIS WAY RIGHT NOW. 
 
 Slightly/Not at all A little Moderately Quite a bit Extremely
1. Interested 1 2 3 4 5 
2. Distressed 1 2 3 4 5 
3. Excited 1 2 3 4 5 
4. Upset 1 2 3 4 5 
5. Strong 1 2 3 4 5 
6. Guilty 1 2 3 4 5 
7. Scared 1 2 3 4 5 
8. Hostile 1 2 3 4 5 
9. Enthusiastic 1 2 3 4 5 
10. Proud 1 2 3 4 5 
11. Irritable 1 2 3 4 5 
12. Alert 1 2 3 4 5 
13. Ashamed 1 2 3 4 5 
14. Inspired 1 2 3 4 5 
15. Nervous 1 2 3 4 5 
16. Determined 1 2 3 4 5 
17. Attentive 1 2 3 4 5 
18. Jittery 1 2 3 4 5 
19. Active 1 2 3 4 5 





















Appendix I: Money Choice Questionnaire 
 
For each of the next 27 choices, please circle which one you would prefer if given the 
choice between the two: would you rather have the smaller reward today, or wait the 
specified number of days and take the larger reward? Please answer EVERY question.  
 
Please take the choices seriously: they may be for REAL MONEY. If you have any 
questions regarding this, please ask. 
 
1. Which would you rather have? 
a. $49 today   b. $60 in 89 days 
2. Which would you rather have? 
a. $47 today   b. $50 in 160 days 
3. Which would you rather have? 
a. $54 today   b. $80 in 30 days 
4. Which would you rather have? 
a. $27 today   b. $50 in 21 days 
5. Which would you rather have? 
a. $41 today   b. $75 in 20 days 
6. Which would you rather have? 
a. $55 today   b. $75 in 61 days 
7. Which would you rather have? 
a. $34 today   b. $35 in 186 days 
8. Which would you rather have? 
a. $34 today   b. $50 in 30 days 
9. Which would you rather have? 
a. $22 today   b. $25 in 136 days 
10. Which would you rather have? 
a. $80 today   b. $85 in 157 days 
11. Which would you rather have? 
a. $14 today   b. $25 in 19 days 
12. Which would you rather have? 
a. $19 today   b. $25 in 53 days 
13. Which would you rather have? 
a. $15 today   b. $35 in 13 days 
14. Which would you rather have? 
a. $25 today   b. $30 in 80 days 
15. Which would you rather have? 
a. $33 today   b. $80 in 14 days 
16. Which would you rather have? 
a. $54 today   b. $55 in 117 days 
17. Which would you rather have? 
a. $54 today   b. $60 in 111 days 
18. Which would you rather have? 





19. Which would you rather have? 
a. $69 today   b. $85 in 91 days 
20. Which would you rather have? 
a. $78 today   b. $80 in 162 days 
21. Which would you rather have? 
a. $20 today   b. $55 in 7 days 
22. Which would you rather have? 
a. $31 today   b. $85 in 7 days 
23. Which would you rather have? 
a. $24 today   b. $35 in 29 days 
24. Which would you rather have? 
a. $40 today   b. $55 in 62 days 
25. Which would you rather have? 
a. $67 today   b. $75 in 119 days 
26. Which would you rather have? 
a. $28 today   b. $30 in 179 days 
27. Which would you rather have? 





























Appendix J: Drug Use Questionnaire 
 
The following questions will ask whether you have used certain types 
of drugs. Please circle the number that indicates whether you have used 





1. Have you ever used cannabis (for example, hash, marijuana, 
THC, or other)? 
 
    1 0 
2. Have you ever used alcohol? 
 
    1 0 
3. Have you ever used cocaine (for example, intranasal, IV, crack, 
freebase, “speedball,” or other)? 
 
    1 0 
4. Have you ever used MDMA (also known as Ecstasy, E, and X)? 
 
    1 0 
5. Have you ever used stimulants that were not prescribed for you 
by a doctor (for example, amphetamine, “speed,” crystal meth, 
dexadrine, Ritalin, “ice”)? 
 
    1 0 
6. Have you ever used sedatives, hypnotics, or anxiolytics that 
were not prescribed for you by a doctor (for example, Xanax, 
Quaaludes, Valium, Librium, barbiturates, Miltown, Ativan, 
Dalmane, Halcion, Restoril, Seconal, or other)? 
 
    1 0 
7. Have you ever used opiates that were not prescribed for you by 
a doctor (for example, heroin, morphine, opium, Methadone, 
codeine, Demerol, Darvon, Perdocan, Dilaudid, or other)? 
 
    1 0 
8. Have you ever used hallucinogens other than PCP (for example, 
LSD, mescaline, peyote, psilocybin, STP, mushrooms, “angel 
dust,” or other)? 
 
    1 0 
9. Have you ever used PCP? 
 
    1 0 
10. Have you ever used inhalants (for example, glue, gasoline, paint, 
nitrous oxide, “laughing gas,” or other)? 
 
    1 0 
11. Have you ever used nicotine (for example, cigarettes, dip, chew, 
cigar, or other)? 








Please circle the answer that is correct for you. 
 














1a. About how often did you 
use cannabis (i.e., marijuana) 
in the past year? 
 
0 1 2 3 4 5 
1b. During the period in your 
life when you were using 
cannabis/marijuana most 
frequently, about how often 
were you using? 
 
0 1 2 3 4 5 
2a. About how often did you 
use alcohol in the past year? 
 
0 1 2 3 4 5 
2b. During the period in your 
life when you were using 
alcohol most frequently, 
about how often were you 
using? 
 
0 1 2 3 4 5 
3a. About how often did you 
use cocaine in the past year?  
 
0 1 2 3 4 5 
3b. During the period in your 
life when you were using 
cocaine most frequently, 
about how often were you 
using? 
 
0 1 2 3 4 5 
4a. About how often did you 
use ecstasy in the past year? 
 
0 1 2 3 4 5 
4b. During the period in your 
life when you were using 
ecstasy most frequently, 
about how often were you 
using? 
 
0 1 2 3 4 5 
5a. About how often did you 0 1 2 3 4 5 
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5b. During the period in your 
life when you were using 
stimulants most frequently, 
about how often were you 
using? 
 
0 1 2 3 4 5 
6a. About how often did you 
use sedatives in the past 
year?  
 
0 1 2 3 4 5 
 
 
6b. During the period in your 
life when you were using 
sedatives most frequently, 





















7a. About how often did you 
use heroin in the past year? 
 
0 1 2 3 4 5 
7b. During the period in your 
life when you were using 
heroin most frequently, about 
how often were you using? 
 
0 1 2 3 4 5 
8a. About how often did you 
use hallucinogens in the past 
year?   
 
0 1 2 3 4 5 
8b. During the period in your 
life when you were using 
hallucinogens most 
frequently, about how often 
were you using? 
 
0 1 2 3 4 5 
9a. About how often did you 
use PCP in the past year? 
0 1 2 3 4 5 
9b. During the period in your 0 1 2 3 4 5 
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life when you were using 
PCP most frequently, about 
how often were you using? 
 
10a. About how often did 
you use inhalants in the past 
year? 
 
0 1 2 3 4 5 
10b. During the period in 
your life when you were 
using inhalants most 
frequently, about how often 
were you using? 
 
0 1 2 3 4 5 
11a. About how often did 
you use nicotine in the past 
year? 
0 1 2 3 4 5 
11b. During the period in 
your life when you were 
using nicotine most 
frequently, about how often 
were you using? 
0 1 2 3 4 5 


























1. How often during the past year have you found that you were not 
able to stop using drugs once you had started?  
 
Never   Less than Monthly Monthly   Weekly   Daily or almost daily 
(0)  (1)       (2)         (3)         (4) 
 
2. How often during the past year have you failed to do what was 
normally expected from you because of your drug use?  
 
Never  Less than Monthly Monthly      Weekly    Daily or almost daily (0)
  (1)         (2)       (3)             (4) 
 
3. How often during the past year have you had a feeling of guilt or 
remorse after using drugs?  
 
Never  Less than Monthly Monthly      Weekly    Daily or almost daily (0)
  (1)         (2)       (3)             (4) 
 
4. How often during the past year have you been unable to remember 
what happened the night before because you had been using drugs?  
 
Never  Less than Monthly Monthly      Weekly    Daily or almost daily (0)
  (1)         (2)       (3)             (4) 
 
5. How often during the past year have you used drugs to keep yourself 
from experiencing withdrawal symptoms?  
 
Never  Less than Monthly Monthly      Weekly    Daily or almost daily (0)
  (1)         (2)       (3)             (4) 
 
6. Have you or someone else been injured as a result of your drug use? 
 
   No  Yes, but not in the past year  Yes, in the past year 
   (0)          (1)                           (2) 
 
7. Has a relative or friend, or a doctor or other health worker been 
concerned about your drug use or suggested you cut down or stop? 
 
   No  Yes, but not in the past year  Yes, in the past year 









Appendix K: I-7 
 
Instructions: Please answer each question by putting a circle around the ‘YES’ or the ‘NO’ 
following the questions. There are no right or wrong answers, and no trick questions. Work 
quickly and do not think too long about the exact meaning of the question. 
1. Do you often buy things on impulse?         YES  NO 
 
2. Do you generally do and say things without stopping to think?     YES  NO 
 
3. Do you often get in a jam because you do things without thinking? YES  NO 
 
4. Are you an impulsive person?      YES  NO 
 
5. Do you usually think carefully before doing anything?   YES  NO 
 
6. Do you often do things at the spur of the moment?   YES  NO 
 
7. Do you mostly speak without thinking this out?   YES  NO 
 
8. Do you often get involved in things you later 
      wish you could get out of?       YES  NO 
 
9. Do you get so ‘carried away’ by new and exciting ideas 
      that you never think of possible snags?     YES  NO 
 
10. Do you need to use a lot of self-control to keep out of trouble?  YES  NO 
 
11. Would you agree that almost everything enjoyable is 
      illegal or immoral?       YES  NO 
 
12. Are you often surprised at people’s reactions to what you do or say? YES  NO 
 
13. Do you think an evening out is more successful if it is unplanned 
      or arranged at the last moment?     YES  NO 
 
14. Do you usually work quickly, without bothering to check?  YES  NO 
 
15. Do you often change your interests?     YES  NO 
 
16. Before making up your mind, do you consider all the 
      advantages and disadvantages?     YES  NO 
 
17. Do you prefer to “sleep on it” before making decisions?  YES  NO 
 
18. When people shout at you, do you shout back?   YES  NO 
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